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 22 
Abstract 23 
Objective: The objective of this review was to summarize the best available evidence regarding the 24 
effectiveness of non-pharmacological interventions to treat orthostatic hypotension (OH) in elderly 25 
people and people with a neurological condition. 26 
Introduction: Orthostatic hypotension is common in elderly people and people with a neurological 27 
condition and can interfere with or limit rehabilitation. Non-pharmacological interventions to treat OH 28 
could allow for longer and earlier mobilization, which is recommended in national clinical guidelines 29 
for rehabilitation in the acute or sub-acute phase following stroke or other neurological conditions. 30 
Inclusion criteria: The review considered people aged 50 years and older, and people aged 18 years 31 
and elderly people with a neurological condition. Non-pharmacological interventions to treat OH 32 
included compression garments, neuromuscular stimulation, physical counter-maneuvers, aerobic or 33 
resistance exercises, sleeping with head tilted up, increasing fluid and salt intake, and timing and size 34 
of meals. The comparator was usual care, no intervention, pharmacological interventions, or other 35 
non-pharmacological interventions. Outcome measures included systolic blood pressure, diastolic 36 
blood pressure, heart rate, cerebral blood flow, observed/perceived symptoms, duration of standing or 37 
sitting in minutes, tolerance of therapy, functional ability, and adverse events/effects.  38 
Methods: Databases for published and unpublished studies available in English up to April 2018 with 39 
no lower date limit were searched. Critical appraisal was conducted using standardized instruments 40 
from JBI. Data were extracted using standardized tools designed for quantitative studies. Where 41 
appropriate, studies were included in a meta-analysis; otherwise, data were presented in a narrative 42 
form due to heterogeneity. 43 
Results: Forty-three studies—a combination of randomized controlled trials (n=13), quasi-44 
experimental (n=28), case control (n=1), and case report (n=1)—were included. A total of 1084 45 
participants met the criteria for inclusion. Meta-analysis was conducted for seven studies, which 46 
concluded that electrical stimulation, lower limb compression, and resistance exercise training were 47 
favorable in treating or reducing OH. However, the 95% confidence intervals for standardized mean 48 
difference crossed zero, and the confidence intervals in resistance exercise training were wide. 49 
Physical maneuvers such as leg crossing, leg muscle pumping/contractions, and bending forward 50 
improved orthostatic hypotension. Abdominal compression improved OH. Sleeping with head up in 51 
combination with pharmacological treatment was more effective than sleeping with head up alone. 52 
Eating smaller, more frequent meals was effective. Drinking 480 mL of water increased blood 53 
pressure.  54 
Conclusions: The review found mixed results for the effectiveness of non-pharmacological 55 
interventions to treat OH in people aged 50 years and older, and people with a neurological condition. 56 
There are several non-pharmacological interventions effective in treating OH, but not all have resulted 57 
in clinically meaningful changes in outcome. Some may not be suitable for people with moderate to 58 
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severe disability; therefore, it is important for clinicians to consider the patient’s abilities and 59 
impairments when considering which non-pharmacological interventions to implement. 60 
Key words: Elderly, older adults; neurological condition; non-pharmacological treatment; orthostatic 61 
hypotension  62 
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Summary of Findings 64 
Resistance exercise compared to usual care for treating orthostatic hypotension in elderly people and 
people with a neurological condition  
 
Bibliography: Effectiveness of non-pharmacological interventions to treat orthostatic hypotension in elderly 
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Change in systolic blood pressure from supine to 
one-minute standing or 60 degrees head-up tilt 
Change in systolic blood pressure assessed with 
mmHg 
Follow-up: range 8 weeks to 12 weeks  
148 
(1 RCT, 2 
experimental)  
⨁◯◯◯ 
VERY LOW a,b,c 
-  SMD 0.86 SD 
lower 
(CI: 2.34 
lower to 0.63 
higher)  
CI: confidence interval; RCT: randomized controlled trial; SD: standard deviation; SMD: standardized mean 
difference  
GRADE Working Group grades of evidence 
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect 
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to 
the estimate of the effect, but there is a possibility that it is substantially different 
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different 
from the estimate of the effect 
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be 
substantially different from the estimate of effect  
Explanations 
a. Before and after study, non-blinded, or blinding of investigators not reported.  
b. Variation in intervention: supervised sessions in Brilla; training performed four days per week in Zion, three days per week in Brilla, twice a week in 
Kanegusuku. 
c. Small sample size in Zion, one-third of which were withdrawn during the intervention phase.  
 65 
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Electrical stimulation compared to usual care for treating orthostatic hypotension in elderly 
people and people with a neurological condition 
 
Bibliography: Effectiveness of non-pharmacological interventions to treat orthostatic hypotension in elderly 
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Change in mean arterial blood pressure 
when moving from supine to one-minute 
standing or a vertical position on a tilt 
table following electrical stimulation 
compared with no intervention, robotic 
stepping, and electrical stimulation 
combined with robotic stepping compared 
with no intervention (change in mean 
arterial blood pressure when moving from 
supine to one-minute standing or a 
vertical position on a tilt table (MAP 
change)) 













*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk 
in the comparison group and the relative effect of the intervention (and its 95% CI).  
 
CI: Confidence interval; SD: standard deviation; SMD: standardized mean difference  
GRADE Working Group grades of evidence 
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect 
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of 
the effect, but there is a possibility that it is substantially different 
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the 
estimate of the effect 
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different 
from the estimate of effect  
Explanations 
a. Observational study. No allocation concealment in Kuznetsov, participants randomized on day of admission  
b. Heterogeneity in population, (e.g. stroke or spinal cord injury) and length of intervention (up to 30 days in Kuznetsov versus all testing on one-day 
Yoshida)  
c. Yoshida made conclusions based on muscle strength and cerebral blood flow, they did not make any conclusions about effect of intervention on 
orthostatic reactions, yet this was one of their objectives.  
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Compression bandaging compared to usual care for treating orthostatic hypotension in 
elderly people and people with a neurological condition 
 
Bibliography: Effectiveness of non-pharmacological interventions to treat orthostatic hypotension in elderly 
people and people with a neurological condition: a systematic review. JBI Evid Synth. 2020;18(4):??-??. 























Change in mean arterial blood pressure 
when moving from supine to one-
minute in sitting following compression 
bandaging compared with no 
intervention (Change in mean arterial 
blood pressure from supine to one-
minute in sitting (MAP change)) 








-  -  SMD 0.16 SD 
lower 
(0.41 lower to 
0.09 higher)  
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk 
in the comparison group and the relative effect of the intervention (and its 95% CI).  
 
CI: Confidence interval; SD: standard deviation; SMD: standardized mean difference  
GRADE Working Group grades of evidence 
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect 
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of 
the effect, but there is a possibility that it is substantially different 
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the 
estimate of the effect 
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different 
from the estimate of effect  
Explanations 
a. Observational study (residual confounding, evidence)  
b. Before and after study, long-term effects not investigated. Study investigated seating induced orthostatic hypotension 
and did not measure effects in standing  
c. Lead author and multiple co-authors were the same in both papers.  
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 69 
Introduction <level 1 heading> 70 
Orthostatic (postural) hypotension (OH) is a common clinical phenomenon in elderly people and 71 
people with a neurological condition.1-4 The consensus definition is a sustained drop of at least 20 72 
mmHg in systolic blood pressure (sBP) and/or at least 10 mmHg in diastolic blood pressure (dBP) 73 
within three minutes of moving from supine to standing, or following head-up tilt to at least 60 74 
degrees.5,6 75 
Orthostatic hypotension has both non-neurogenic and neurogenic causes and can be acute or 76 
chronic.6 Non-neurogenic causes fall into three categories: hypovolemia (reduced blood volume), 77 
cardiac pump failure, and venous pooling. Neurogenic OH is associated with neurological diseases 78 
and can be caused by abnormalities in either the central nervous system (e.g. stroke, spinal cord 79 
injury, Parkinson’s disease) or peripheral nervous system (e.g. Guillain Barré syndrome, diabetic 80 
neuropathy)7. 81 
Orthostatic hypotension can cause a variety of symptoms and is a common cause of syncope 82 
(transient loss of consciousness, rapid onset, and short duration) that may contribute to morbidity, 83 
disability, and even death because of the potential risk of substantial injury.5 Other characteristic 84 
symptoms include dizziness/light-headedness and pre-syncope; weakness, fatigue, and lethargy; 85 
palpitations and sweating; visual disturbances (including blurring, enhanced brightness, and tunnel 86 
vision); hearing disturbances (including impaired hearing, crackles, and tinnitus); and neck pain 87 
(occipital/para-cervical and shoulder region), low back pain, or precordial pain.8,9 These symptoms 88 
relate to the degree of the fall in blood pressure and hypoperfusion (reduced blood flow) of the brain 89 
and other organs, and can vary in severity. 90 
The prevalence of OH in elderly people (defined for this review as age 50 years and older10) is high, 91 
both in the United Kingdom (UK) and internationally, but varies depending on the characteristics of 92 
the population studied. It is more prevalent in elderly people who are hospitalized and institutionalized 93 
(up to 68%)11 than in those living in the community (30%),12 likely a reflection of the multiple disease 94 
processes, including neurological and cardiac conditions, as well as the type and number of 95 
prescribed medications. In addition, orthostatic changes in BP become more exaggerated after 96 
prolonged immobilization.13 The prevalence of OH in people with neurological conditions is also high. 97 
Systematic reviews have concluded that OH occurs in approximately 40% of people with Parkinson’s 98 
disease2 and 50% to 82% of people with spinal cord injury, depending on the level of lesion.3 It is also 99 
common in people with stroke,1414 occurring in up to 52%.4 Given that stroke predominantly occurs in 100 
elderly people, it is possible that the prevalence of OH post-stroke may be much higher. This aligns 101 
with current European guidelines, which highlight that OH is underdiagnosed.5 102 
The presence of OH can interfere with and limit rehabilitation, especially after stroke and spinal cord 103 
injury where early mobilization (out-of-bed activities such as sitting, standing, and walking within 48 104 
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hours) is recommended.15-18 Early mobilization has demonstrated improved functional outcomes17; 105 
however, studies of early mobilization in people with acute stroke excluded participants from the 106 
intervention arm if they had OH on three consecutive occasions.18,19 Given the high incidence of OH 107 
in this population, this exclusion criterion could impact recruitment rates and generalizability of the 108 
findings of trials of early mobilization interventions, and ultimately influence the number of people 109 
potentially benefitting from these interventions. 110 
The risk of harm with OH must be acknowledged and addressed. In acute and sub-acute stroke, OH 111 
has the potential to cause additional brain damage both in the area surrounding the stroke 112 
(penumbra) and throughout the brain due to hypoperfusion, a consequence of impaired cerebral 113 
autoregulation.20 This may result in increased disability and mortality. Considering this risk of harm, it 114 
is surprising that current guidelines for the management of people with stroke15,21,22 do not provide 115 
guidance on managing OH. 116 
The goal of managing OH is to increase the patient’s standing BP without also increasing their resting 117 
BP and specifically to reduce OH symptoms, increase the time the patient can stand, and improve the 118 
patient’s ability to perform activities of daily living.23 Currently, there is no specific intervention that 119 
achieves all of these goals, despite the multitude of pharmacological and non-pharmacological 120 
interventions available. A recent systematic review highlighted that although there were multiple 121 
pharmacological interventions available in the UK, Europe, and the United States of America (USA), 122 
there are few high-quality data as to which intervention the best.24 Furthermore, the review concluded 123 
that there are limited data on the benefits of long-term pharmacological interventions in people with 124 
OH in terms of the effects on postural BP changes as well as symptom relief. The burden of 125 
pharmacological interventions also warrants consideration. People with stroke and elderly people are 126 
more likely to have multimorbidity25 and thus are at risk of polypharmacy (taking five medications or 127 
more).26 Therefore, identifying non-pharmacological interventions to treat OH in elderly people and 128 
people with stroke is paramount. 129 
Reviews27 and guidelines5,28 from the USA and Europe for the management of OH recommend non-130 
pharmacological interventions as first-line treatment before progressing to pharmacological 131 
interventions. However, people with neurological conditions often have complex needs and severe 132 
disability, which means that some non-pharmacological interventions may not be appropriate. For 133 
example, undertaking physical maneuvers requires a specific level of mobility and balance, and 134 
functional electrical simulation may be contraindicated due to other medical conditions or skin frailty. 135 
Therefore, these guideline recommendations cannot be automatically translated to people with 136 
neurological conditions, which underpins the rationale for this review. Non-pharmacological 137 
interventions for OH, such as compression garments, are used to treat OH in elderly people and 138 
those with spinal cord injury and Parkinson’s disease,29,30 and could be applicable to people with 139 
stroke. However, non-pharmacological interventions are not commonly used, and there is a lack of 140 
clear guidance on their use. In line with this, previous reviews of standing in people with neurological 141 
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conditions31 have highlighted this as a research priority for people with OH, for elderly people, and 142 
adults with a neurological disease.32 143 
An initial search of the literature in MEDLINE, Embase, CINAHL, Cochrane Database of Systematic 144 
Reviews, and PROSPERO identified one systematic review from Canada examining studies that 145 
evaluated non-pharmacological interventions to treat OH.33 However, this review was broad, covering 146 
various patient populations and not restricted to elderly people or people with a neurological condition. 147 
Furthermore, the review did not focus on any specific outcomes, such as impact on mobilization or 148 
functional ability, thus identifying the need for a systematic review in this area. This review, together 149 
with a systematic review of pharmacological interventions,24 will allow the development of a protocol 150 
to enable the assessment and treatment of OH in elderly people and people with neurological 151 
conditions. 152 
Review question <level 1 heading> 153 
What is the evidence base for non-pharmacological interventions in treating orthostatic hypotension 154 
(OH) in elderly people and people with a neurological condition? 155 
Review objectives 156 
The objectives of the review are to determine the effectiveness of non-pharmacological interventions 157 
for OH in elderly people and people with a neurological condition. 158 
Inclusion criteria <level 1 heading> 159 
Participants <level 2 heading> 160 
The current review considered studies that included participants who were:  161 
• Diagnosed with OH by a medical professional using criteria such as the International 162 
Classification of Diseases and Related Health Problems, 10th revision (ICD-10)34  163 
AND 164 
• Classified as elderly (defined as 50 years or over). Currently, there is no consensus definition 165 
of “elderly,” ‘‘older,’’ or ‘‘old people,’’ with 50 years accepted as the definition of elderly 166 
people based on the World Health Organization Older Adult Health and Ageing in Africa 167 
project10  168 
AND/OR 169 
• Aged 18 years and over with progressive or sudden, non-progressive neurological condition 170 
of the central nervous system; peripheral nervous system conditions were excluded. 171 
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Participants receiving treatment for acute or chronic OH were included, which encompassed 172 
treatment carried out in hospitals, outpatient clinics, in-patient rehabilitation units, and the community 173 
(either in their own homes, or in a residential or nursing home setting). 174 
Interventions <level 2 heading> 175 
The review considered studies that evaluated non-pharmacological interventions to treat OH. These 176 
included compression garments (e.g. lower limb compression stockings or abdominal corset); 177 
neuromuscular stimulation; physical maneuvers (e.g. squatting and bending at the waist) and 178 
isometric exercises (muscle contractions against a resistant that are not associated with any 179 
movement of the limb) for arms, lower limbs, and abdominal muscles during standing; raising the 180 
head of bed at night time; or increasing fluid and salt intake. However, a full systematic search 181 
identified additional interventions that were considered (e.g. frequency and size of meals). 182 
Interventions of any duration, frequency, or intensity were considered. 183 
Comparators <level 2 heading> 184 
The review considered studies that compared the non-pharmacological interventions listed previously 185 
with usual care, no intervention, pharmacological interventions, and/or other non-pharmacological 186 
interventions. 187 
Outcomes <level 2 heading> 188 
Outcomes considered included sBP and/or dBP (both sBP and/or dBP in lying and standing using 189 
manual or automated device); time to symptoms and time to recovery; resting heart rate (HR) using 190 
manual or automatic device; cerebral blood flow using transcranial Doppler or correlation 191 
spectroscopy and others; observed and/or perceived symptoms; duration of standing or sitting in 192 
minutes; tolerance of therapy (e.g. ability to participate in therapy as measured by length and 193 
frequency of sessions); function/activities of daily living; other outcomes not previously identified; and 194 
adverse events/effects where this information was provided. 195 
Types of studies <level 2 heading> 196 
This review considered experimental and epidemiological study designs including randomized 197 
controlled trials (RCTs), non-RCTs, quasi-experimental, before and after studies, prospective and 198 
retrospective cohort studies, and case-control studies. In addition, descriptive epidemiological study 199 
designs, including case series, and individual case reports were also considered. 200 
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Methods <level 1 heading> 201 
This systematic review was conducted in accordance with the JBI methodology for systematic reviews 202 
of effectiveness35 and according to an a priori protocol (PROSPERO CRD42020167022).36 203 
Search strategy <level 2 heading> 204 
The initial search was carried out in January 2017 and updated in April 2018, and aimed to find both 205 
published and unpublished studies. A three-step search strategy was utilized. An initial limited search 206 
of MEDLINE, AMED, CINAHL, and Embase was undertaken, followed by analysis of the text words 207 
contained in the title and abstract, and of the index terms used to describe the articles. A second 208 
search using all identified keywords and index terms was then undertaken across all included 209 
databases. Third, the reference lists of all studies that met the inclusion criteria were searched for 210 
additional studies. The search was restricted to studies published in English, as team members were 211 
unable to translate other languages. There were no date limits.  212 
Information sources <level 3 heading> 213 
Databases that were searched included MEDLINE (Ovid), Embase (Ovid), Cochrane Central Register 214 
of Controlled Trials, CINAHL, AMED (EBSCO), PEDro, ClinicalTrials.gov, and OpenGrey. A search 215 
for unpublished studies was carried out in Google Scholar and Conference Papers Index. Appendix I 216 
provides the search strategy from all databases. 217 
Study selection <level 2 heading> 218 
Following the search, all identified citations were uploaded into EndNote X8 (Clarivate Analytics, PA, 219 
USA) bibliographic software37 and duplicates removed. Titles and abstracts were screened by two 220 
independent reviewers for assessment against the inclusion criteria for the review. The full text of 221 
potentially eligible studies was retrieved and assessed in detail against the inclusion criteria by two 222 
independent reviewers. The details of studies that met the inclusion criteria were imported into the JBI 223 
System for the Unified Management, Assessment and Review of Information (JBI SUMARI; JBI, 224 
Adelaide, Australia).38 Any disagreements that arose between the reviewers were resolved through 225 
discussion, or with a third reviewer. 226 
Assessment of methodological quality <level 2 heading> 227 
Selected studies were critically appraised by two independent reviewers for methodological quality 228 
using the standardized critical appraisal instruments from JBI for the following study types: 229 
randomized controlled trials, quasi-experimental studies, case control studies, and case reports.39 230 
Disagreements were resolved through discussions, negating the requirement for a third reviewer. In 231 
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accordance with the aim to be as comprehensive as possible, all studies meeting the inclusion criteria 232 
were included in the review, regardless of the quality score. 233 
Data extraction <level 2 heading> 234 
Quantitative data were extracted from papers using the standardized data extraction tool available in 235 
JBI SUMARI39 by two independent reviewers (AL, JM, JP, JF, SB, and EC). The data extracted 236 
included specific details about the interventions, populations, study methods, outcomes of 237 
significance, and specific objectives. 238 
Authors of papers were contacted to request missing or additional data where required. Thirteen 239 
authors were contacted, and responses were received from five. 240 
Data synthesis <level 2 heading> 241 
Due to the variability and heterogeneity in the parameters of the papers presented, it was not possible 242 
to include all papers in the meta-analyses. For papers not included in the meta-analyses, data are 243 
presented as mean +/- standard deviation (SD) unless otherwise stated, alongside the narrative 244 
summary. 245 
Outcomes for papers included in the meta-analyses were as follows: the change in mean arterial BP 246 
between supine and maximum upright stand or tilt (depending on what the studies measured) at the 247 
earliest measurement point (e.g. selecting measurements at one minute rather than two minutes, if 248 
both available). Where mean arterial pressure was not available, it was calculated with constant 249 
proportions between dBP and sBP: mean arterial pressure = 1/3 sBP + 2/3 dBP (mmHg).40 Where 250 
dBP data were not available, the change in sBP was used. 251 
Results, where possible, were pooled in statistical meta-analysis using JBI SUMARI. Effect sizes were 252 
expressed as standardized mean differences and their 95% confidence intervals calculated for 253 
analysis. Treatment effects were interpreted using Hedge’s G magnitude of the standardized mean 254 
difference41. Standardized mean difference takes into account measurement variability, unlike the 255 
mean difference. Mean difference has greater statistical power and can be used if the minimally 256 
important change (MIC) is known42. However, there is no MIC for OH and the standardized mean 257 
difference is more therefore felt to be generalizable42. Heterogeneity was assessed statistically using 258 
the standard chi-squared and I2 tests. The choice of random effects model and methods for meta-259 
analysis were based on the guidance by Tufanaru et al.43 There were insufficient individualized data 260 
to conduct subgroup analyses,39 and insufficient number of studies to generate a funnel plot.44 261 
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Assessing certainty in the findings <level 2 heading> 262 
A Summary of Findings was created using GRADEpro software (McMaster University, ON, Canada) 263 
for all studies included in the meta-analysis. The GRADE approach for grading the quality of evidence 264 
was followed.45 The Summary of Findings presents the following information, where appropriate: 265 
absolute risks for treatment and control, estimates of relative risk, and a ranking of the quality of the 266 
evidence based on study limitations (risk of bias), indirectness, inconsistency, imprecision, and 267 
publication bias.45-48 The following outcomes were considered critical and were included in the 268 
Summary of Findings: mean arterial blood pressure and systolic blood pressure. 269 
Results <level 1 heading> 270 
Study inclusion <level 2 heading> 277 
The results of the search and study selection process are presented in Figure 1.49 A total of 4481 278 
potentially relevant studies were identified. Table 5 shows the total number of relevant studies 279 
identified for each database. Of those, 1080 were duplicates. From the remaining 3401 records, 3316 280 
were excluded after title and abstract assessment. The eligibility of 85 full-text articles were assessed, 281 
42 of which were excluded. The methodological quality of the remaining 43 studies were assessed, 282 
which included 13 randomized control trials, 28 quasi-experimental studies, one case-control study 283 
and one case report. 284 
<Insert Figure 1 here> Reference for PRISMA50 285 
  286 
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Methodological quality <level 2 heading> 287 
Methodological quality in all studies varied, but were included to provide a comprehensive review. 288 
Table 1 presents the critical appraisal of the 13 RCTs included in the systematic review. True 289 
randomization was not used in one study, unclear in six studies, and used in six studies (Q1). 290 
Concealed allocation to treatment was used in five studies and unclear in four studies (Q2). Quality 291 
criteria relating to blinding of participants, clinicians, and researchers scored poorly in most studies 292 
(Q4 and Q5). Follow-up was either complete, or strategies to address incomplete follow-up were 293 
utilized in nine studies (Q8), and nine studies analyzed participants in the groups to which they were 294 
randomized (Q9).<Insert Table 1 here> 295 
Table 2 presents the results of the critical appraisal for eligible quasi-experimental studies. Cause and 296 
effect was clear in all but one study (Q1). In five studies, Q2 and Q3 were not applicable because 297 
there were no comparisons made. There was no control group in nine of the 28 studies (Q4). 298 
Question 7 was deemed not applicable to one study because no comparisons were made. 299 
<Insert Table 2 here> 300 
Confounding factors were not identified (Q6) and no strategies to deal with confounding factors were 301 
present (Q7) in the case-control study. All other aspects of methodological quality were met (Table 302 
3).<Insert Table 3 here> 303 
 304 
Table 4 presents the critical appraisal results for the eligible case report. The post-intervention clinical 305 
condition was not clearly described (Q5), but all other aspects of methodological quality were 306 
reported. 307 
<Insert Table 4 here> 308 
Characteristics of included studies <level 2 heading> 309 
Date of publication of studies ranged from 1984 to 2018, and all were published in English. In the 310 
following sections, the main features of these studies are summarized. Detailed information about the 311 
settings, participants, methods, interventions, outcomes, and results are provided in Appendix II. 312 
Study settings <level 3 heading> 313 
Twenty of the included studies were undertaken in Europe (four in United Kingdom51-54, one in 314 
Ireland55, six in the Netherlands,56-61 three in Italy,62-64 two in Germany,65,66 one in Austria,67 one in 315 
France,68 and two in Switzerland69,70. Of the remaining 22 studies, 10 were undertaken in the USA,71-316 
80, three in Israel,81-83 two in Canada,84,85 two in Brazil,86,87 one in India,88 one in Malaysia,89 one in 317 
Russia,90 one in New Zealand,91 and one in Australia92 and it was unclear in which country one study 318 
was undertaken.93 The interventions described were undertaken in hospital settings,53,54,61,63,69,70,78,81-319 
83,92 rehabilitation facilities,62,64,65,68,76,77,88-90 outpatient clinics or centers,51,55,58,71,75,85,86 320 
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laboratories,52,56,57,59,60,66,72,79,84,91, or community settings.67,73,74,80,87 It was unclear which setting on 321 
study was conducted in93. 322 
Participants <level 3 heading> 323 
The 43 studies analyzed included a total of 1,069 participants, ranging from one (case report study61) 324 
to 128 (quasi-experimental study90). The age range of all participants was reported in 20 studies51,53,56-325 
61,67-69,72,75,76,79,80,84,85,89,92 and was from 18 to 89 years. Twenty-two studies52,54,55,62-65,70,71,73,74,77,78,81-326 
83,86-88,90,91,93 reported mean age. One study reported the age range for participants with autonomic 327 
failure and the mean age for nine participants with idiopathic OH.66 There was a total of 440 elderly 328 
(≥50 years) participants. 329 
Approximately 48% of all participants were male. Six studies included only males,61,68,76,78,89,91 16 330 
studies included more males than females,51,53,58,64,65,67,69,72,77,79,84,85,87,88,92,93 two studies had an equal 331 
number of males and females,54,59 two studies reported the gender of participants with 332 
OH/neurological conditions but did not report gender for control participants.60,71 333 
Studies in this systematic review included participants with OH (n=362), stroke (n=170), spinal cord 334 
injury (n=86), Parkinson’s disease (n=57), brain injury (n=28), brain hemorrhage (n=18), syncope 335 
(n=21), familial dysautonomia (n=17), primary autonomic/autonomic failure (n=52), multi-system 336 
atrophy (n=31), cardiac arrhythmias (n=10), dizziness/palpitations (n=27), infectious diseases (n=21), 337 
pulmonary edema (n=10), acute coronary syndrome (n=11), decompensated heart failure (n=18), 338 
other conditions (n=39), and also healthy control participants (n=91). Four of the 1,069 participants 339 
had both spinal cord injury and OH, and others had multiple conditions. 340 
Inclusion criteria for studies varied. Fourteen studies had OH as an inclusion criterion with a specific 341 
definition: 10 studies defined OH as a decrease in sBP of >20mmHg or a decrease in dBP >10mmHg 342 
after a change in posture.55,62,67,74,80-83,88,89 Other definitions were a decrease in sBP >30mmHg or a 343 
decrease in dBP >15mmHg72; sBP decrease by at least 40mmHg or dBP decrease by at least 344 
30mmHg93; a decrease in sBP of >30mmHg or a decrease in dBP >20mmHg75, and progressive 345 
decrease in BP below a value of 90mmHg.63 Eleven studies had OH as an inclusion criterion but did 346 
not provide a definition of OH.51-54,56-60,66,73, Nine studies had an age inclusion criterion of elderly 347 
people: ≥50 years,87 ≥60 years,55,80,82,83 or ≥65 years62,70,81 or specified an age range74 (60 to 85 348 
years) Nineteen studies had neurological conditions as an inclusion criterion.61,64,65,67-72,76-78,84,85,87-90,92 349 
Interventions/comparators <level 3 heading> 350 
Eight non-pharmacological interventions for OH were identified under two general categories: physical 351 
modalities (exercise, electrical stimulation, compression, physical counter-maneuvers, compression 352 
and physical counter-maneuvers, and sleeping with head up) and dietary measures (food and fluid 353 
intake), which aim to treat OH by raising standing blood pressure without raising supine blood 354 
pressure to increase the time people can stand and improve their ability to perform activities of daily 355 
living. 356 
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Review findings <level 2 heading> 357 
Physical modalities <level 3 heading> 358 
Exercise 359 
Exercise included aerobic training using a cycle ergometer, resistance/strength training using 360 
resistance bands or weights, passive stepping using robotic tilt tables, and upper limb exercises. Nine 361 
studies included in this systematic review evaluated the effects of exercise on OH. Participants 362 
included in these studies had spinal cord injury,78 brain injury,62,64,65,69,74,80,86,87 brain haemorrhage,69 363 
stroke,69 neurocardiogenic syncope,86 Parkinson’s disease,87 and OH.62,74,8062,88,90 364 
Four studies64,65,78,86 used tilt tables, three of which64,65,86 used robotic tilt tables where participants 365 
with brain injury undertook passive stepping while being tilted up to 65 degrees64,65 and 70 degrees.86 366 
Duration of intervention periods were different: two sessions of sequential testing65 (intended duration 367 
of testing in minutes not reported) and 24 sessions, each 30 minutes, three times per week.64 The 368 
fourth study78 used a tilt table and included participants with spinal cord injury who performed upper 369 
limb exercises while being tilted up to 70 degrees. 370 
The effect of aerobic physical training was used in one study86 for participants with neuro-cardiogenic 371 
syncope. Participants undertook a 12-week supervised program of moderate aerobic intensity training 372 
using a cycle ergometer. Training took place twice a week and lasted for 35 minutes, and patients 373 
were instructed to perform two additional unsupervised sessions. 374 
One study69 examined the effect of passive stepping at 30, 50, and 70 degrees using a robotic tilt 375 
table, automated cycling in supine versus standard care (defined as mobilization with 376 
physiotherapist), for patients with severe brain injury.  377 
Four studies62,74,80,87 examined the effects of resistance training on elderly people with OH. In one 378 
study,62 participants performed 10 full extensions of the ankle, knee, and hip joints of both limbs 379 
starting from 60 degrees flexion of hips and 90 degrees flexion of knee and ankle joints against a 380 
resistance band (6-kg load) that participants positioned under the soles of their forefeet and firmly 381 
held at both ends while supine in bed prior to standing up. Participants in the three remaining 382 
studies74,80,87 undertook a home-based resistance program, which incorporated exercises for both 383 
upper and lower limbs. These three studies were included in a meta-analysis (Figures 2, 3, and 4).78 384 
Six studies62,64,69,78,86,87, in the exercise category had a control group, which consisted of tilting 385 
only,62,64,78 standard care,69,87 and stretching and light walking.86 In one study65 participants acted as 386 
their own controls in a randomized crossover design. Two studies included in the meta-analysis 387 
(Figure 2) did not include a control group.74,8062,88 388 
<Insert Figure 2 here> 389 
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Electrical stimulation 390 
Electrical stimulation is a technique that uses low energy electrical pulses to artificially generate a 391 
muscle contraction of paralyzed muscles. When used in a functional context to elicit patterns of 392 
movement, it is also referred to as functional electrical stimulation. The studies included in this review 393 
used electrical stimulation of upper limbs, lower limbs, and abdomen.  394 
Seven studies examined the effects of electrical stimulation on OH.71,76,77,84,85,89,90 Participants in one 395 
study90 had a stroke; the other six studies included people with spinal cord injury. Two papers71,77 396 
reporting on the same study included the same sample and examined the same experimental 397 
interventions, differing slightly in the measured outcomes. They compared upright stationary standing 398 
versus upright dynamic standing using functional electrical stimulation, both using a standing 399 
apparatus for 30 minutes on the same day. Another repeated measures study76 positioned 400 
participants in multiple tilt angles (0, 15, 30, 45, and 60 degrees), four minutes at each angle followed 401 
by four minutes recovery, repeated with and without electrical stimulation to the lower limb (bilateral 402 
knee extensors and ankle plantar flexor muscles). One study89 included two participants who 403 
underwent four weeks of electrical stimulation to trunk and lower-limb muscles (rectus abdominis, 404 
quadriceps, hamstrings, and gastrocnemius muscles), four times per week for one hour per day. One 405 
study84 tested the capacity of electrical stimulation, applied transcutaneously over the spinal cord 406 
(approximately corresponding to the T8 spinal segment) to manage OH in participants with spinal 407 
cord injury. Two studies85,90 used a robotic tilt table and electrical stimulation to compare passive 408 
stepping and passive stepping combined with electrical stimulation. These were included in a meta-409 
analysis (Figure 3). 410 
<Insert Figure 3 here> 411 
Use of control group varied: three studies included a control group,48,65,71 two studies55,68 had no 412 
control group, and participants acted as their own controls in one study.64,86 413 
Compression 414 
Compression involves using various types of bandages and garments on different body parts, 415 
commonly the lower limbs and abdomen. Fourteen studies51,57,61,63,67,68,72,75,81-83,88,91,92 examined the 416 
effect of compression on OH. Participants were elderly with OH,51,63,72,81-83 had acute stroke,88 417 
Parkinson’s disease,67 neurogenic OH,75,63, autonomic dysfunction,57, healthy older and younger 418 
adults91 spinal cord injury.61,68,92 419 
Two studies,63,88 both RCTs, examined the effect of compression to both the abdomen and lower 420 
limbs. In one study,63 elderly participants with OH wore ankle to thigh bandages for 10 minutes, then 421 
an abdominal bandage was added for a further 10 minutes. Participants then wore leggings, which 422 
covered from the mid foot to the abdomen, for one month at home. Authors reported that these were 423 
worn daily but did not report any recommendations or report usage from follow-up data. In the other 424 
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study,88 participants with acute stroke wore a pneumatic abdominal binder and pneumatic calf 425 
compression for six consecutive sessions for approximately 15 minutes during progressive incline on 426 
a tilt table. 427 
Four studies57,67,72,92 examined the effect of abdominal compression on OH. Participants with 428 
Parkinson’s disease67 were enrolled into a randomized crossover trial. They wore an abdominal 429 
binder or placebo binder. Participants then wore an abdominal binder every day (time not specified) 430 
for four weeks. The second study,72 a randomized crossover trial, assessed the effects of a 431 
conventional or patient-controlled adjustable abdominal binder on OH. Binders were worn for 432 
approximately 10 minutes during the testing period. The third study57 tested the effect of abdominal 433 
compression (maximal pressure protocol 1 and graded compression protocol 2) of participants with 434 
autonomic dysfunction. The fourth study92 enrolled participants with spinal cord injury into a 435 
randomized crossover trial. Participants wore an abdominal binder (pressure not reported) daily (time 436 
not specified) for six months.  437 
Three studies examined the effect of lower limb compression during tilt tabling,51,61,75 all of which used 438 
different compression garments and different pressures on different body parts. In one study,75 439 
participants with neurogenic OH underwent tilt testing with and without compression applied to calves, 440 
thighs, and abdomen using an inflatable G-suit to evaluate the impact of compression of different 441 
body parts on orthostatic BP and tolerance. Another study,61 a case report, tested one participant with 442 
spinal cord injury on a tilt table with and without inflatable external leg compression to bilateral lower 443 
limbs. The third study51 tested elastic compression hosiery (tights covering the legs and abdomen) 444 
fitted to bilateral lower limbs in elderly participants. 445 
One study68 examined the effects of a wheelchair ergometer with and without graduated compression 446 
stockings. Participants with spinal cord injury used the wheelchair ergometer twice: once with garment 447 
compression stockings and once without a week later. Additional details are presented in Appendix II. 448 
One study91 examined the effect of compression leggings at normal body temperature and a long-449 
sleeved and legged, two piece, tube-lined perfusion suit at elevated body temperature in healthy 450 
elderly people and younger adults. 451 
Three studies81-83 examined the effect of lower limb compression bandages from ankle to thigh on 452 
OH. All three studies included elderly participants who were hospitalized due to acute medical 453 
conditions,81 decompensated heart failure,82 and OH.83 In all three studies, compression bandages 454 
were applied along both legs from ankle to thigh before sitting without compression and repeated with 455 
compression. In one study,81 compression was approximately 30mmHg at the ankle. The remaining 456 
two studies used 40mmHg compression82 and 30-40mmHg compression83 at the ankle. The latter two 457 
studies were included in a meta-analysis (Figure 4). 458 
<Insert Figure 4 here> 459 
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In 10 studies, participants acted as their own controls,51,57,67,68,72,75,81-83,910 two studies had a control 460 
group,63,88 and two studies had no control group.61,92 461 
Physical counter-maneuvers 462 
Physical counter-maneuvers are specific movements or exercises such as squatting, leg crossing, or 463 
tensing specific muscles with the aim of increasing standing BP and reducing OH. Five 464 
studies56,58,60,73,93 were identified in the literature search that examined the effect of physical counter-465 
maneuvers on OH, varying in the number and type of maneuvers performed. Participants in these 466 
studies had OH due to pure autonomic failure,56,58,60 neurogenic OH,73 and familial dyautomonia.93 467 
One study73 examined the use of multiple physical counter-maneuvers for three to four months 468 
following a training period. Training consisted of four training sessions in the laboratory performing the 469 
physical counter-maneuvers. Participants were then asked to perform the three selected maneuvers 470 
at home for three to four months when symptomatic. 471 
In one study,60 all participants performed leg-crossing and squatting in a fixed order. Participants 472 
stood for 10 minutes maximum or until symptoms occurred, then performed leg-crossing in standing 473 
for 30 seconds then resumed normal standing. When BP dropped again, participants squatted for 30 474 
seconds then resumed the normal standing position. 475 
In one study,56 participants performed nine different maneuvers, each for one minute serially, 476 
separated by 30 to 60 seconds of standing. Participants were asked to sit on seats of varying heights 477 
(48 cm, 38 cm, 20 cm), with or without leg-crossing, squatting, and standing in a crossed-leg position 478 
with or without additional contraction of the lower limb muscles. All maneuvers were repeated twice 479 
and performed in a random order. 480 
One study93 examined the effect of four physical counter-maneuvers (bending forward, squatting, and 481 
leg crossing in a random order) in 17 participants with familial dysautonomia. Participants also 482 
completed a fourth physical counter-maneuver using abdominal compression. 483 
One study58 compared leg muscle pumping or tensing for one minute, commencing after two minutes 484 
of active standing, compared to active standing only.  485 
Three studies did not include a control group,56,73,93 and two studies included a control group.58,60 486 
Physical counter-maneuvers and compression 487 
Two studies used a combination of physical counter-maneuvers and compression. One study5780 488 
examined the effects of abdominal compression and physical maneuvers in participants with 489 
neurogenic hypotension. Participants maintained a standing position with the abdominal binder and 490 
then performed physical maneuvers in standing while wearing an anti-gravity suit. For nine 491 
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participants, the duration of standing was extended (duration not specified) by standing without 492 
crossed legs or abdominal compression. As soon as a stable low BP was obtained for 30 seconds, 493 
the counter-maneuvers were repeated for 90 seconds, followed by a short period of normal standing. 494 
Nine participants (unclear if it was the same nine who undertook extended standing) performed two 495 
active standing maneuvers; external abdominal compression was applied by elastic binder. 496 
Another study93 compared the effect of physical counter-maneuvers, one of which was abdominal 497 
compression. Participants performed four counter-maneuvers (bending forward, squatting, leg 498 
crossing, abdominal compression) in a randomized order and abdominal compression using an 499 
inflatable belt. Outcomes were measured before and after 500 
Sleeping head-up tilt 501 
One study55 examined the effect of sleeping with the head of the bed elevated by six inches for six 502 
weeks. The control group received no intervention. Another study59 examined the effect of sleeping 503 
with the head of bed elevated with and without pharmacological intervention and 2,000mL water per 504 
day. There was no control group, but there was a control period during the first week. 505 
 506 
Dietary measures <level 3 heading> 507 
Food intake 508 
Studies in this category examined the size and frequency of meals and their effect on OH. Three 509 
studies53,70,79 examined the effect of food intake on OH. 510 
One study70 tested participants with Parkinson’s disease and 10 age-matched controls over two 511 
consecutive days to examine the change in sBP induced by meals. They also compared the impact of 512 
orthostatic sBP response in participants with Parkinson’s disease with that of control participants. 513 
One study79 examined the effect of meal size and the time of day on OH in elderly and young healthy 514 
participants. 515 
The final study53 examined the effect of meal size and number of meals in people with autonomic 516 
failure. All participants underwent the same conditions: the first day participants ate three meals 517 
versus the second day (at least one day apart) when participants ate six meals. Total calorie intake 518 
was the same over both days. 519 
Participants acted as their own controls in two studies,53,70 and one study did not include a control 520 
group.79 521 
Fluid intake 522 
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Ingesting water to increase BP and attenuate OH was examined in three studies.52,54,66 Participants in 523 
all three studies drank 480 mL of fluid; however, additional variables such as food intake and exercise 524 
were also studied. 525 
One study52 examined the effect of ingesting water before exercise on OH. All participants had severe 526 
pre-exercise OH and underwent the same testing using a cycle ergometer. Testing was undertaken 527 
on two separate occasions, one in which participants drank 480 mL distilled water. 528 
A second study66 examined the effect of water ingestion and food intake. All participants underwent 529 
two protocols. In protocol 1, participants drank 480 mL of tap water; in protocol 2, participants drank 530 
480mL of water immediately before eating the test meal. 531 
The final study54 in the category examined the effects of drinking 480 mL distilled water. All 532 
participants had autonomic failure and underwent the same testing: standing BP was measured 533 
before, and 15 and 35 minutes after ingesting of 480 mL distilled water. 534 
Two studies52,66 did not include a control group, and in the third study87 participants acted as their own 535 
controls. 536 
 537 
Follow-up and measurement intervals <level 2 heading> 538 
Follow-up periods varied: 30 days,71 one month,56 four weeks,50,68 eight weeks,62,88,59 12 weeks,52,58 539 
three to four months,61 and 14 months.81  540 
Outcomes <level 2 heading> 541 
A wide variety of outcome measures were used in the included studies. Several outcomes included in 542 
this review were not identified a priori and have been highlighted in the limitations section. The most 543 
common objective outcomes were sBP and/or dBP, (used in all 43 studies) and HR,52-59,61-66,68-75,78-544 
81,84,86-93 cardiac output,52,54-58,68,71,75,77,91,93 and stroke volume.52,54-58,61,68,71,77,84,85,90,91,93. Other objective 545 
outcomes included the following: total peripheral resistance,52,54-57,71,77,91,93 mean arterial 546 
pressure,55,71,77,84,89,91-93 mean BP,56,58-60,67,69,73,85,93 oxygen saturations,61,81,82 respiratory rate,69 547 
resistance index,73,90 HR variability,68 stroke index,73 cardiac index,61,73,75 maximum power output,68 548 
maximum systolic velocity,90 minimum diastolic velocity,90 end diastolic index,73 peripheral resistance 549 
index,75 end diastolic volume index,75 pulsatility index,90 systemic vascular resistance,58 inferior caval 550 
vein,57 femoral vein,57 rate pressure product,77 perfusion index,61 cerebral blood flow,69,90 blood 551 
velocity of middle and posterior cerebral artery,84 cerebral vascular resistance,91 calf impedence,93 552 
electrocardiographic RR-intervals,87,93 Valsalva maneuvers,66,87 hyperventilation test,66 cold pressor 553 
test,52,66 oxygen uptake,68 end-tidal partial pressure of carbon dioxide,91 peak expiratory flow,92 forced 554 
expiratory flow,92 forced vital capacity,92 voice measures,92 interruption of verticalization,65 maximal 555 
cardiopulmonary exercise test,86 fluid balance,55,59 esophageal temperature,91 venous blood and 556 
plasma samples,69 and edema.5549 557 
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Observed or perceived orthostatic symptoms were measured using a variety of methods. The most 558 
common method was self-report,53-56,59,60,76,81-83,85,89 where participants described their symptoms. One 559 
study84 asked participants to rank their symptoms from one to 10. Other studies used formal outcome 560 
measures: Specific Symptom Scale Questionnaire for Orthostatic Intolerance,63 global symptomatic 561 
improvement score,73 Orthostatic Symptom Scale,72 severity of OH symptoms,75 orthostatic 562 
tolerance,59 Symptom Change Scale,72 Orthostatic Hypotension Questionnaire,67 OH Daily Activity 563 
Scale,67 and OH Symptom Assessment.67 564 
Two studies measured maximum standing time.52,59 Three studies used measures of disability and 565 
function: Timed Up and Go Test,80 Barthel Index90 and modified Rankin Scale.88 Other measures 566 
were measures of muscle strength,52,66,80,87,90 one repetition maximum,74,87 and electromyography of 567 
leg muscles.85  568 
Physical modalities <level 3 heading> 569 
Exercise interventions delivered during tilt tabling demonstrated mixed results. Greater tolerance of 570 
verticality and reduced occurrence of OH was observed in three studies.64,65,78 Passive stepping using 571 
robotic tilt tables was effective at reducing the number of OH symptoms,64,65 and this was also 572 
observed when performing upper limb exercises during verticalization.78 A 12-week aerobic training 573 
program86 resulted in an increase in orthostatic tolerance and reduction of positive head-up tilt tests. 574 
Lower limb resistance exercises62 were the least effective, resulting in minimal reduction in an initial 575 
fall in sBP when moving from supine to standing. No significant absolute or relative difference was 576 
observed in any of the BP components with passive cycling or passive stepping.69 However, there 577 
was a higher difference in arterial BP in both the intervention groups compared with standard 578 
physiotherapy. Three studies74,80,87 investigating the effects of resistance exercise training were 579 
included in a meta-analysis (Figure 2), which concluded that resistance exercise training was 580 
favorable compared to no intervention. A large mean effect size of -0.86 was observed favouring the 581 
intervention however the 95% confidence intervals for the standardized mean difference crossed zero 582 
and were wide (-2.34-+0.63). Figure 2 also shows show significant heterogeneity (P<0.0001) of 583 
studies.  584 
Conclusion of effectiveness: Exercise interventions may improve orthostatic tolerance, but there were 585 
no statistically significant results with any of the exercise interventions.  586 
Electrical stimulation was favorable but not statistically significant in the five studies not included in 587 
the meta-analysis. In these studies, participants using electrical stimulation could stand for longer and 588 
had reductions in OH,71,77 demonstrated a longer tolerance time during head-up tilt,89 and had 589 
normalized BP.76,84 The overall outcome of the two studies85,90 included in the meta-analysis (Figure 590 
3) showed that a combination electrical stimulation and robotic stepping was more effective than 591 
robotic stepping only or control. 592 
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Conclusion of effectiveness: Results for the studies not included in the meta-analysis favored the 593 
intervention of electrical stimulation, but were not statistically significant. A comparison of robotic 594 
stepping and electrical stimulation (ROBO-FES) with robotic stepping (ROBO) showed a small effect 595 
size (-0.32) favouring ROBO-FES but with 95% CI that cross zero (-0.80 to 0.17). A comparison of 596 
robotic stepping and electrical stimulation (ROBO-FES) with control showed a small effect size (-0.44) 597 
favouring ROBO-FES but with 95% CI that cross zero (-0.92 to 0.04).Compression demonstrated 598 
positive results for elderly people with OH and people with neurogenic OH. Two studies63,88 concluded 599 
that combined lower limb and abdominal compression improved orthostatic stability in elderly people 600 
and people with stroke.  601 
Abdominal compression57,67,72 was shown to reduce OH in elderly people with neurogenic OH. 602 
Abdominal compression significantly reduced BP fall upon tilting67 compared to placebo. Symptoms of 603 
OH decreased significantly at the four-week follow-up. Abdominal compression was effective at 604 
attenuating OH compared with no abdominal compression,72 and symptoms were not affected by type 605 
of binder. There was no statistically significant difference with or without abdominal binder92; however, 606 
mean arterial BP was higher with the abdominal binder at six weeks and at six months. 607 
Three lower limb compression studies reported positive results. Maximum improvement was observed 608 
with all three combinations of compression (calves, thighs and abdomen),75 and abdominal 609 
compression alone significantly reduced OH (P<0.005). Similarly, a significant improvement was 610 
observed in elderly people with OH wearing elastic hosiery tights,51 with a reduction of OH at one 611 
minute (P<0.01) and at two minutes (P<0.005). The spinal cord injury case report61 demonstrated that 612 
the individual was able to remain in the upright position for longer, allowing improved mobilization 613 
during physiotherapy while wearing the inflatable external leg compression. The inflatable external leg 614 
compression succeeded in improving pre-syncope symptoms and preventing OH for several hours. 615 
Participants with spinal cord injury demonstrated an increase in sympathetic activity and a decrease 616 
in parasympathetic activity after maximal exercise while wearing graduated compression stockings 617 
using the wheelchair cycle ergometer.68 618 
Lower limb compression stockings91 caused a passive physical resistance that, upon standing, 619 
delayed the maximal drop in mean arterial pressure in both younger adults and elderly people. The 620 
authors of the study concluded that compression stockings appeared to reduce venous pooling; 621 
however, the total peripheral resistance increased in elderly participants in minute 6. There were no 622 
differences between groups when heat and orthostatic stress were combined.  623 
Lower limb compression bandages81 decreased OH symptoms in participants who were medically 624 
unwell, including 14 with stroke. Approximately 55% of participants experienced symptoms in the un-625 
bandaged group. Significant changes were observed in the un-bandaged group compared to the 626 
bandaged group, with significantly greater incidence of palpitations, tachycardia, and decline of 627 
oxygen saturation over time (P<0.04, P<0.03, P<0.03, respectively). The authors did not report results 628 
for sBP or dBP. Results from the two studies82,83 included in the meta-analysis (Figure 4) favor 629 
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compression bandaging, but the effect size was small and the 95% confidence interval cross zero (-630 
0.16 95% CI -0.41 to 0.09). 631 
Conclusion of the effectiveness: Lower limb and abdominal compression,51,63,88 lower limb 632 
compression,51,61,68,81-83,91 and abdominal compression57,67,72,92 are effective in improving OH; 633 
however, not all studies were statistically significant. 634 
Physical counter-maneuvers were deemed effective in reducing OH in people with neurogenic OH, 635 
if performed correctly.73 Squatting produced the most dramatic change in arterial BP, resulting in 636 
longer standing time improved. The follow-up survey identified that the use of the maneuvers varied 637 
from once to 11 times per day (3.83 ±3.1 maneuvers per day). However, the follow-up survey was 638 
conducted via telephone; therefore, it was unknown whether participants were performing maneuvers 639 
correctly. 640 
Leg crossing and squatting60 improved standing BP in people with autonomic failure. After leg 641 
crossing, all participants stood for 10 minutes or more (pre-intervention standing times not provided). 642 
Time in standing after squatting was not reported. 643 
Leg crossing and leg muscle contractions56 resulted in higher standing BP than without leg muscle 644 
contraction. Leg crossing while sitting on 48-cm and 38-cm chairs demonstrated an increase in sitting 645 
BP in people with pure autonomic failure. 646 
Leg muscle pumping (tiptoeing and leg crossing)58 had different effects on OH in people with 647 
autonomic failure. Tiptoeing did not change BP after one minute in the patient group, but the 648 
normative group showed an increase in BP. Leg-crossing increased BP in both groups initially, which 649 
was more pronounced in the normative group. 650 
Physical maneuvres93 that significantly increased mean BP included bending forward (P<0.005), 651 
squatting (P<0.002), and abdominal compression (P<0.04) but not leg crossing. Squatting and 652 
abdominal compression also induced a significant increase in cardiac output during squatting 653 
(P<0.02) and during abdominal compression (P<0.014). 654 
Conclusion of effectiveness: Physical counter-maneuvers,60,73,93 leg crossing,56,60,93 leg muscle 655 
pumping/contractions,56 squatting and bending forward93 improved OH, while tiptoeing did not.58  Leg 656 
crossing while sitting on 48-cm and 38-cm chairs demonstrated an increase in sitting BP.56 657 
A combination of abdominal compression and physical counter-manouvres had a significant 658 
effect on standing BP in one study (P<0.0557) and significant increase in cardiac output in another 659 
study (P=0.0272). However, there were no significant differences in the effect of abdominal 660 
compression on the diameter of caval or femoral veins, or compression and arterial pressure 661 
response.57  662 
Conclusion of the effectiveness: A combination of abdominal compression and physical counter-663 
maneuvers is effective in treating OH. 664 
JBI Database of Systematic Reviews and Implementation Reports 
18-00005 copyedited clean_OH 30_03_2020 formatted refs  Page 24 
Sleeping with head up reduced BP after one minute of standing (P<0.01 for sBP).59 Four of the six 665 
participants adopted this intervention. Combined treatment (sleeping with head up and 666 
pharmacological treatment using fludrocortisone) was most effective, significantly reducing OH 667 
symptoms in all patients (P<0.001) and increasing the maximal standing period to at least 10 minutes 668 
compared to 35 to 170 seconds pre-treatment. Sleeping with head up at six inches for six weeks had 669 
no effect on OH symptoms and BP.55 670 
Conclusion of the effectiveness: Sleeping with head up in combination with fludrocortisone was more 671 
effective than sleeping with head up alone. 672 
Dietary measures <level 3 heading> 673 
Food intake had a negative effect on BP in elderly people and people with neurogenic OH. 674 
Participants with Parkinson’s disease had a significant (P<0.01) postprandial sBP drop in supine 675 
position compared to healthy controls.70 There was a greater fall in sBP with passive versus active 676 
standing in both groups, with a greater postprandial fall in the group with Parkinson’s disease. The 677 
authors reviewed one meal (lunch) and did not look at all meals throughout an entire day or collect 678 
data on the size of meals participants usually ate with those provided in the study. 679 
Post-meal BP was lower in all positions53 (lying sBP P<0.005, lying dBP P<0.02, sitting dBP P<0.07, 680 
standing dBP P<0.06) after three large meals. Compared to six meals, sBP and dBP between meals 681 
reached lower levels on the three-meal study day. Fewer symptoms were reported during the six-682 
meal study day.  683 
Post-meal supine BP was significantly lower (P<0.02) in elderly participants.79 Supine sBP and dBP 684 
were significantly higher (P<0.15 and P<0.001) in the elderly group, but standing sBP and dBP were 685 
similar between groups. 686 
Conclusion of effectiveness: Eating smaller, more frequent meals as opposed to larger, less frequent 687 
meals resulted in significantly higher supine, sitting, and standing BP and improved OH symptoms in 688 
people with autonomic failure, people with neurogenic OH, elderly people, and people with 689 
Parkinson’s disease. 690 
Fluid intake prior to standing had a positive effect on OH in various positions. Five minutes after 691 
drinking water, there was a significant rise in BP in the supine position (P<0.05).52 With exercise there 692 
was a clear fall in BP, which occurred even after water ingestion. Blood pressure remained low after 693 
exercise but was significantly higher (P<0.05) after water intake, resulting in better tolerance of post-694 
exercise standing. Drinking water improved orthostatic tolerance post-exercise. Standing prior to 695 
water ingestion caused a significant fall (P<0.01) in BP in all participants.66 After water ingestion, there 696 
was a rise in seated BP. Seated and standing BP at 15 and 35 minutes after water ingestion was 697 
significantly higher (P<0.01 and P<0.001) than before water, with an improvement in orthostatic 698 
symptoms. 699 
Drinking 480 mL of water at room temperature in less than five minutes improved standing BP and 700 
orthostatic tolerance in people with autonomic failure.54 The response was similar in patients with 701 
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multiple system atrophy and those with pure autonomic failure. Water ingested before a meal 702 
attenuated postprandial hypotension in these patients. Drinking water also attenuated orthostatic 703 
tachycardia in people with idiopathic orthostatic intolerance. 704 
Conclusion of effectiveness: Ingestion of water increased BP in supine,70 sitting,78 and standing.78,87 705 
Water ingested prior to a meal also attenuated postprandial hypotension.87 706 
Discussion <level 1 heading> 707 
This review set out to examine the effectiveness of non-pharmacological interventions to treat OH in 708 
elderly people and people with a neurological condition. 709 
Although the literature contained many non-pharmacological interventions to treat OH in these 710 
populations, the review highlighted a heterogeneity of methods. The inclusion criteria included some 711 
participants who did not have a formal diagnosis of OH prior to entering a study. Many studies 712 
included participants with neurological conditions such as Parkinson’s disease, brain injury, stroke 713 
and spinal cord injury, but did not specify OH as an inclusion criterion. This may be because OH in 714 
neurological conditions is associated with central autonomic dysfunction or the absence of vein blood 715 
pump related to lower limb paralysis. Additionally, periods of immobility or prolonged bed rest, which 716 
can cause physiological changes such as diminished sympathetic activity,94 in combination with 717 
hypovolemia, may also predispose some individuals with neurological conditions to OH. However, 718 
authors did not explicitly provide this as a rationale for their chosen sample. 719 
Thirty-one percent of studies specified OH in their inclusion criteria, but there was heterogeneity in the 720 
definitions used, and only 26% provided a definition, which makes meaningful comparison difficult. 721 
The most commonly used definition was a sustained drop in sBP of at least 20 mmHg and/or dBP of 722 
at least 10 mmHg following a change of posture, which was applied to various postures (standing, 723 
tilting [ranging from 15 to 90 degrees tilt angles], or sitting). Other variations used a higher 724 
threshold.72,75,93 Using higher thresholds could result in participants being missed during screening. It 725 
also raises the question as to whether the lack of standardization observed in these studies is 726 
mirrored in clinical practice. The time points at which BP was measured also varied from 727 
immediately62,63 to up to 10 minutes74,90 of being upright. Further, the definition of “being upright” 728 
varied from 60 to 90 degrees on a tilt table or self-initiated standing, and authors did not acknowledge 729 
or discuss the differences between active and passive standing. Verticalization using a tilt table does 730 
not fully replicate the physiology of active standing because the exercise reflex and the mechanical 731 
squeeze on the venous capacitance and arterial resistance vessels are less.95 Therefore, OH may 732 
occur more frequently with tilt-table testing.96 733 
Cerebral hypoperfusion is acknowledged in clinical guidelines5,28 as a common cause of syncope or 734 
transient loss of consciousness,97 which is likely to impact standing time and symptoms experienced. 735 
Monitoring cerebral blood flow is important in people with acute or sub-acute stroke, because 736 
autoregulation is impaired following stroke.20 Two recent meta-analyses98,99 concluded that OH was 737 
independently associated with a significantly higher risk of developing coronary heart disease, 738 
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cardiovascular disease, and heart failure. Despite the relative importance of maintaining cerebral 739 
blood flow when standing upright, it was measured in only two studies. One study69 monitored 740 
cerebral blood flow, but only in participants with sub-arachnoid hemorrhage and not in participants 741 
with ischemic stroke or severe brain trauma. The authors acknowledged the potential risk of impairing 742 
cerebral blood flow during mobilization but did not provide a rationale for only monitoring participants 743 
with sub-arachnoid hemorrhage. Additionally, they did not provide any data on cerebral blood flow. 744 
The second study90 included 104 participants with stroke (128 recruited but 28 dropped out), all of 745 
whom had cerebral blood flow measured pre- and post-training. Cerebral blood flow was reduced 746 
≤10%, but participants were asymptomatic. Asymptomatic OH is more common than symptomatic 747 
OH,100 which means clinicians may be unaware of the potential risk of further brain damage when 748 
these patients are being mobilized or undergoing therapy. As well as measuring cerebral blood flow, 749 
future work should investigate what is a clinically important drop in cerebral blood flow. 750 
Which interventions worked? <level 2 heading> 751 
Overall, the results were mixed. Although effect sizes often favored the intervention in individual 752 
studies, meta-analyses of three interventions were statistically non-significant. The mean effect sizes 753 
were either large (resistance exercise) or small (electrical stimulator or compression bandaging) and 754 
in all cases the95% confidence intervals for the standardized mean difference crossed the line of no 755 
effect as highlighted in the forest plots in Figures 2, 3, and 4. In general the sample sizes were small 756 
and although there were differences seen these are small and this has potentially been influenced by 757 
the small sample sizes. Of the additional interventions reviewed, physical counter-maneuvers and 758 
fluid intake produced favorable results. It is important to consider the feasibility and practicality of 759 
these interventions if they are to be implemented into clinical practice. 760 
Physical counter-maneuvers were favorable in reducing OH, for example, but people with balance 761 
and mobility problems may find many of the physical maneuvers challenging, and their risk of falling 762 
increased. Additionally, performing these physical maneuvers requires the ability to stand and move 763 
between sitting and standing, and people with moderate and severe disability would often not be able 764 
to perform these movements without mechanical or physical assistance. Exercise was favorable, but 765 
the changes measured were not statistically significant. The resistance training programs may also be 766 
unsuitable for people with moderate to severe disability. Several studies used robotic tilt tables and 767 
automated cycle ergometers to passively move lower limbs during verticalization, which may be more 768 
suitable for people with neurological conditions who have moderate to severe disability. When 769 
considering implementation into practice, it is important to consider how accessible this equipment is; 770 
robotic tilt tables, for instance, are not routinely available in clinical practice. 771 
Other interventions that may be suitable for people with moderate to severe disability are 772 
compression and electrical stimulation. Compression garments, such as compression stockings, may 773 
allow repeated safe standing or sitting. They can be used in conjunction with tilt tables and standing 774 
frames to facilitate orthostatic tolerance, and are commonly used in spinal cord rehabilitation.101 In 775 
stroke, current clinical guidelines recommend intermittent pneumatic compression or graded 776 
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compression stockings of lower limbs as thromboembolism prophylaxis.102 Therefore, abdominal 777 
binders may be more appropriate as they would not interfere with this. Furthermore, abdominal 778 
binders may be easier for healthcare providers to monitor skin integrity, and they provide less risk of 779 
skin damage. However, abdominal binders are contraindicated for people receiving nutritional support 780 
via a gastrostomy tube, because the binder would compress the tube and may cause pain and skin 781 
damage. Additionally, people with moderate to severe disability may need assistance to don and doff 782 
compression garments. 783 
Electrical stimulation is an adjunctive intervention commonly used in clinical practice to treat muscle 784 
impairment.103 Contraindications for electrical stimulation include poor skin integrity, significant 785 
autonomic dysreflexia in incomplete spinal cord injury above T6, and uncontrolled epilepsy.104 Only 786 
one study provided this information.89 None of the studies discussed the contraindications of using 787 
electrical stimulation in clinical practice. However, contractions induced by electrical stimulation of 788 
lower limb muscles may activate the skeletal muscle pump as effectively as voluntary contractions of 789 
these muscles in people without weakness or disability as a result of stroke or neurological 790 
impairment. This may allow patients to stand earlier or for longer during rehabilitation sessions or 791 
performing activities of daily living. The two studies included in the meta-analysis investigating the 792 
effectiveness of electrical stimulation versus control had small sample sizes and within these there 793 
were significant variability. Although the studies indicate a better absolute effect using electrical 794 
stimulation, this is not reflected in the meta-analysis. This is due to the variability and the small 795 
sample size. 796 
Water ingestion had a positive effect on OH and would be suitable for many people. However, stroke 797 
and degenerative neurological conditions can cause swallow impairments105; therefore, ingesting 798 
water quickly may be unsafe or challenging for these people due to risk of aspiration and aspiration 799 
pneumonia. Further, people who have incontinence or reduced mobility that affects their ability to get 800 
to the toilet may be reluctant to undertake this intervention. This intervention would also be unsuitable 801 
for people who have fluid restriction due to other medical conditions. All three studies tested water 802 
ingestion on a one-off basis making the accumulative effects unknown. 803 
Long-term follow-up and prolonged intervention regimes were lacking in most studies. Therefore, it is 804 
unknown whether OH improves over time with repeated application of a specific non-pharmacological 805 
intervention and whether improvements are sustained, alleviating the need for further intervention 806 
over the longer term. None of the studies evaluated instantaneous versus training effects (e.g. 807 
repeated interventions) of the different OH interventions. For example, an abdominal binder improved 808 
OH when it was worn for four weeks,67 but because there was no follow-up beyond this point, it was 809 
not known if symptoms returned once it was no longer worn. This warrants different trial designs with 810 
longer follow-up periods.  811 
Determining long-term effects is important because studies suggest the cardiovascular system can 812 
adapt over time to develop orthostatic tolerance. In spinal cord injury, for example, these adaptations 813 
may be due to changes in Rennin–angiotensin–aldosterone activity.106,107 Further, adaptations in the 814 
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central control of autonomic functions have been identified in healthy animals with prolonged exercise 815 
training and may occur over time and with training in people with OH.108 816 
There may be a difference in the short- and long-term effects of the interventions between conditions. 817 
Where there is direct damage to autonomic centers, such as in multiple system atrophy109 and 818 
Parkinson’s disease,110 the potential for adaptive changes may be limited. In contrast, there may be 819 
greater potential for central and neuro-hormonal adaptive changes in the elderly and in people after 820 
stroke, where causes may be more linked to paralysis and long-term immobility. This highlights the 821 
need for future studies to stratify participants according to both their condition and stage or severity of 822 
disease. Different conditions have different pathophysiological mechanisms underlying OH111-113 and 823 
thus potentially different short- and long-term effects of an intervention. 824 
Limitations <level 2 heading> 825 
The primary limitation of this review was the heterogeneity of methods of the studies included.  826 
Significant variability between studies Most studies had small sample sizes, which limits 827 
generalizability of the results. The methodological quality of the included studies varied. For RCTs, 828 
randomization was not used or unclear, and blinding in most RCTs was low. Some quasi-829 
experimental studies did not include a comparator or control group. The number of participants 830 
included in the meta-analyses varied: electrical stimulation (n=3890 and n=1085), compression (n=5382 831 
and n=7383), and exercise (n=5374; n=1487; n=880). The certainty of the evidence was very low for all 832 
studies included in the meta-analysis, thus any translation into practice must be tentative. Subgroup 833 
analysis was not possible due to insufficient number of studies included in the meta-analysis, as well 834 
as inconsistency of reported demographics, medications, and severity of neurological condition using 835 
disease-specific validated outcome measures. 836 
Outcomes not previously identified in the protocol development were identified through this systematic 837 
review process, and the authors recognize this as a protocol deviation: cardiac output,52,54-838 
58,68,71,75,77,91,93 and stroke volume.52,54-58,61,68,71,77,84,85,90,91,93. Other objective outcomes included the 839 
following: total peripheral resistance,52,54-57,71,77,91,93 mean arterial pressure,55,71,77,84,89,91-93 mean 840 
BP,56,58-60,67,69,73,85,93 oxygen saturations,61,81,82 respiratory rate,69 resistance index,73,90 HR variability,68 841 
stroke index,73 cardiac index,61,73,75 maximum power output,68 maximum systolic velocity,90 minimum 842 
diastolic velocity,90 end diastolic index,73 peripheral resistance index,75 end diastolic volume index,75 843 
pulsatility index,90 systemic vascular resistance,58 inferior caval vein,57 femoral vein,57 rate pressure 844 
product,77 perfusion index,61 cerebral blood flow,69,90 blood velocity of middle and posterior cerebral 845 
artery,84 cerebral vascular resistance,91 calf impedence,93 electrocardiographic RR-intervals,87,93 846 
Valsalva maneuvers,66,87 hyperventilation test,66 cold pressor test,52,66 oxygen uptake,68 end-tidal 847 
partial pressure of carbon dioxide,91 peak expiratory flow,92 forced expiratory flow,92 forced vital 848 
capacity,92 voice measures,92 interruption of verticalization,65 maximal cardiopulmonary exercise 849 
test,86 fluid balance,55,59 esophageal temperature,91 venous blood and plasma samples,69 and 850 
edema.55 851 
This review was further limited by the inclusion of only English language studies. 852 
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Conclusion <level 1 heading> 853 
This review found mixed results for the effectiveness of non-pharmacological interventions to treat OH 854 
in people 50 years and older and people with a neurological condition. The settings, participants, 855 
outcomes, study designs, and intervention types were heterogeneous, resulting in an inability to 856 
include all studies in a meta-analysis. There are several non-pharmacological interventions that may 857 
be effective in treating OH (electrical stimulation, lower limb and abdominal compression, physical 858 
maneuvers, resistance exercise training, eating smaller and more frequent meals, and drinking 480 859 
mL water), but not all have resulted in clinically meaningful changes in outcome. However, those 860 
studies included in the meta-analyses were non-significant, and the 95% confidence intervals for the 861 
standardized mean difference crossed the line of no effect and were wide. Sleeping with head up in 862 
combination with pharmacological treatment was more effective than sleeping with head up alone. 863 
Some interventions may not be suitable for people with moderate to severe disability (e.g. they may 864 
be unable to stand to perform physical maneuvers or perform resistance training due to weakness). 865 
Thus, it is important for clinicians to consider a patient’s abilities and impairments when choosing 866 
which non-pharmacological interventions to implement. 867 
Recommendations for practice <level 2 heading> 868 
The findings of this systematic review have several implications for clinicians working with people with 869 
neurological conditions and elderly people in both inpatient and community settings. Although not 870 
statistically significant, meta-analysis concluded that electrical stimulation, lower limb compression, 871 
and resistance exercise training were favorable in reducing OH, although the GRADE certainty of 872 
evidence was very low for all three physical modalities. These modalities could be implemented into 873 
rehabilitation sessions for people with stroke, people with neurological conditions, and elderly people.  874 
Many rehabilitation units have cycle ergometers (e.g. MOTOmed, Thera Trainers), which patients 875 
could use while sitting out, even in specialist wheelchairs. However, depending on the severity of 876 
disability, some patients may need supervision to optimize safety. Additionally, many rehabilitation 877 
units also have access to functional electrical stimulation (e.g. Microstim), which could be 878 
incorporated into standing practice to increase the duration of standing and optimize physical activity 879 
during rehabilitation sessions. Clinicians need to check whether patients have any contraindications 880 
(e.g. spinal cord injury above T6, uncontrolled epilepsy, poor skin integrity, cognitive problems).  881 
When OH is problematic, lower limb compression and abdominal binders could be used, both within 882 
and outside of rehabilitation sessions, to optimize physical activity. Abdominal binders are easier to 883 
don and doff than lower limb compression stockings, making them easier for patients to use 884 
independently. For those who require assistance with compression, education of clinicians, carers, 885 
and family members is required so that patients can use them within and outside of rehabilitation 886 
sessions, and in the community setting. 887 
The applicability of water ingestion for people with neurological conditions has been acknowledged. If 888 
patients have been screened by speech and language therapists and deemed to have no swallow 889 
impairment, sipping water may be a useful way of managing OH during standing practice. 890 
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This review suggests a range of non-pharmacological interventions may be effective in managing OH. 891 
Most do not require specialist equipment and training; therefore, the cost of implementation is likely to 892 
be minimal. Importantly, from a practical perspective, many of these interventions can be 893 
implemented inside or outside of rehabilitation sessions. However, the patient’s physical abilities and 894 
impairments (e.g. cognitive impairment, severity of disability, swallow impairment) should be 895 
considered when selecting a non-pharmacological intervention. 896 
Recommendations for future research <level 2 heading> 897 
This systematic review highlighted heterogeneity in measurement of non-pharmacological 898 
interventions to treat OH. Lack of a standardized approach to measurement in OH trials makes 899 
consolidation of the body of knowledge difficult, which may negatively impact on effective 900 
interventions being implemented into clinical practice. A consensus is required when measuring BP at 901 
specific time points during standing or verticalization. Further, a consensus is required for measuring 902 
OH in people with neurological conditions who have impaired mobility and reduced standing times. 903 
Additionally, a core set of outcome measures and standardized time points would facilitate pooling of 904 
results in meta-analyses to enable more accurate conclusions to be drawn. 905 
Standardization of inclusion criteria is required to ensure that all participants enrolled in OH 906 
intervention studies have OH, either by testing during screening or from a formal diagnosis. Improved 907 
consistency of methodology reporting, as recommended by the Consolidated Standards of Reporting 908 
Trials guidelines,122 is also recommended. Consistency of reporting demographics, medications, and 909 
severity of neurological condition using disease-specific validated outcome measures would allow 910 
subgroup analysis. 911 
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Appendix I: Search strategy 1205 
Each of the databases listed below were searched individually as part of one search in January 2017. 1206 
The search was repeated on April 26 and 27, 2018 to update the search prior to submission for 1207 
publication. Limiters for all searches: English language. The number of relevant studies identified in 1208 
each database is shown in Table 5. The number of records identified (number of hits for each search 1209 
formula) for each database is shown in the results column on the right-hand side of each table. Advice 1210 
was sought from an information scientist and guidance given to report it in the following ways: 1211 
 1212 
MEDLINE (Ovid) 1213 
Search ID # Search formula Records retrieved 
S1 orthostatic adj2 hypotension AB 641 
S2 hypotension, orthostatic/ MeSH, AB 843 
S3 postural adj2 hypotension AB 88 
S4 orthostasis AB 138 
S5 dizziness/ MeSH AB 2367 
S6 “low blood pressure” AB 322 
S7 hypotension/ MeSH AB 5181 
S8 vascular adj2 response AB 645 
S9 “autonomic dysfunction” AB 1519 
S10 “cerebral blood flow” or “cerebral bloodflow” AB 5119 
S11 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S9 OR S10 16,541 
S12 Elder* OR “older people” OR “older person” OR aged/ OR ageing 
OR aging OR senior OR geriatric AB 
485,281 
S13 S11 AND S12 2436 
S14 "non-pharmacological treatment*" OR "nonpharmacological 
treatment*" OR "non pharmacological treatment*" AB 
455 
S15 "non-pharmacological management" OR "nonpharmacological 
management" OR "non pharmacological management" AB 
79 
S16 "non-pharmacological intervention*" OR "nonpharmacological 
intervention*" OR "non pharmacological intervention*" AB 
547 
S17 14 OR 15 OR 16 1081 
S18 Physical AB 218,418 
S19 S13 AND S18 396 
S20 S11 AND S12 AND S17 9 
S21 S11 AND S17 19 
S22 compression ajd2 garment* AB 90 
S23 compression adj2 stocking* AB 411 
S24 compression adj2 bandag* AB 386 
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S25 compression adj2 wrap* AB 8 
S26 stockings, compression/ AB 321 
S27 abdominal binder AB 13 
S28 S22 OR S23 OR S24 OR S25 OR S26 OR S27 1229 
S29 S13 AND S28 11 
S30 S11 AND S28 23 
S31 S13 AND S17 8 
S32 rehabilitation AB 954 
S33 S13 AND S32 0 
S34 S11 AND S32 1 
S35 exercise AB 12,723 
S36 S35 AND S11 56 
S37 S11 AND “physical maneuvers” or “physical man*” or “physical 
measures” AB 
25 
S38 diet AB and S11 0 
S39 fluid AND S11 0 
S40 water AND S11 0 
S41 meals AND S11 0 
S42 food AND S11 0 
S43 vasovagal AND management OR treatment AB 0 
S44 S11 AND “head up” OR “head-up” AB 16 
S45 S11 and “electrical stimulation” AB 2 
S47 Parkinson* OR Alzheimer* OR dementia OR “multiple sclerosis” 
OR “motor neuron*” OR stroke AB 
188,454 
S47 exp stroke/ MeSH AB 25,475 
S48 exp neurodegenerative disease*/ MeSH AB 52,263 
S49 exp dementia/ MeSH AB 24,907 
S50 exp multiple sclerosis/ MeSH AB 16,962 
S51 exp cerebrovascular disorder/ MeSH AB 47,426 
S52 exp brain ischemia/ MeSH AB 19,725 
S53 exp spinal cord injuries/ MeSH AB 19,147 
S54 exp brain injuries/ MeSH AB 15,167 
S55 craniocerebral trauma/ MeSH AB 2014 
S56 exp central nervous system disease/ MeSH AB 197,427 
S57 exp brain damage, chronic/ MeSH AB 22,074 
S58 Parkinson* adj2 disease AB 20,277 
S59 S47 OR S48 OR S49 OR S50 OR S51 OR S52 OR S53 OR S54 
OR S55 OR S56 OR S57 OR S58 
197,363 
S60 S11 AND S59 2689 
S61 S11 AND S17 AND S59 8 
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S62 S11 AND intervention OR treatment 962 
S63 S11 AND “functional electrical stimulation” OR FES OR “electrical 
stimulation” OR “neuromuscular stimulation”  
0 
 1214 
CINAHL (EBSCO) 1215 
Search ID # Search formula Records retrieved 
S1 orthostatic adj2 hypotension AB 745 
S2 hypotension, orthostatic/ MeSH, AB 1011 
S3 postural adj2 hypotension AB 163 
S4 orthostasis AB 89 
S5 dizziness/ MeSH AB 3615 
S6 “low blood pressure” AB 1220 
S7 hypotension/ MeSH AB 6579 
S8 vascular adj2 response AB 640 
S9 “autonomic dysfunction” AB 992 
S10 “cerebral blood flow” or “cerebral bloodflow” AB 2769 
S11 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S9 OR S10 11,975 
S12 Elder* OR “older people” OR “older person” OR aged/ OR ageing 
OR aging OR senior OR geriatric AB 
770,143 
S13 S11 AND S12 11,975 
S14 "non-pharmacological treatment*" OR "nonpharmacological 
treatment*" OR "non pharmacological treatment*" AB 
586 
S15 "non-pharmacological management" OR "nonpharmacological 
management" OR "non pharmacological management" AB 
160 
S16 "non-pharmacological intervention*" OR "nonpharmacological 
intervention*" OR "non pharmacological intervention*" AB 
319 
S17 14 OR 15 OR 16 909 
S18 Physical AB 254,613 
S19 S13 AND S18 399 
S20 S11 AND S12 AND S17 7 
S21 S11 AND S17 13 
S22 compression ajd2 garment* AB 2039 
S23 compression adj2 stocking* AB 411 
S24 compression adj2 bandag* AB 3136 
S25 compression adj2 wrap* AB 38 
S26 stockings, compression/ AB 411 
S27 abdominal binder AB 32 
S28 S22 OR S23 OR S24 OR S25 OR S26 OR S27 4812 
S29 S13 AND S28 14 
S30 S11 AND S28 40 
JBI Database of Systematic Reviews and Implementation Reports 
18-00005 copyedited clean_OH 30_03_2020 formatted refs  Page 39 
S31 S13 AND S17 7 
S32 rehabilitation AB 83,688 
S33 S13 AND S32 142 
S34 S11 AND S32 3469 
S35 exercise AB 60,566 
S36 S35 AND S11 9 
S37 S11 AND “physical maneuvers” or “physical man*” or “physical 
measures” AB 
1 
S38 diet AB and S11 2 
S39 fluid AND S11 10 
S40 water AND S11 4 
S41 meals AND S11 1 
S42 food AND S11 5 
S43 vasovagal AND management OR treatment AB 2 
S44 S11 AND “head up” OR “head-up” AB 1038 
S45 S11 and “electrical stimulation” AB 2130 
S47 Parkinson* OR Alzheimer* OR dementia OR “multiple sclerosis” 
OR “motor neuron*” OR stroke AB 
67,201 
S47 exp stroke/ MeSH AB 29,841 
S48 exp neurodegenerative disease*/ MeSH AB 1208 
S49 exp dementia/ MeSH AB 15,734 
S50 exp multiple sclerosis/ MeSH AB 5738 
S51 exp cerebrovascular disorder/ MeSH AB 861 
S52 exp brain ischemia/ MeSH AB 478 
S53 exp spinal cord injuries/ MeSH AB 6811 
S54 exp brain injuries/ MeSH AB 9820 
S55 craniocerebral trauma/ MeSH AB 16 
S56 exp central nervous system disease/ MeSH AB 335 
S57 exp brain damage, chronic/ MeSH AB 465 
S58 Parkinson* adj2 disease AB 2403 
S59 S47 OR S48 OR S49 OR S50 OR S51 OR S52 OR S53 OR S54 
OR S55 OR S56 OR S57 OR S58 
731,686 
S60 S11 AND S59 1054 
S61 S11 AND S17 AND S59 1 
S62 S11 AND intervention OR treatment 1018 
S63 S11 AND “functional electrical stimulation” OR FES OR “electrical 
stimulation” OR “neuromuscular stimulation”  
3 
 1216 
Embase (Ovid) 1217 
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Search ID # Search formula Records retrieved 
S1 orthostatic adj2 hypotension AB 12,134 
S2 hypotension, orthostatic/ MeSH, AB 8751 
S3 postural adj2 hypotension AB 8453 
S4 orthostasis AB 1235 
S5 dizziness/ MeSH AB 59,620 
S6 “low blood pressure” AB 1999 
S7 hypotension/ MeSH AB 83,977 
S8 vascular adj2 response AB 4 
S9 “autonomic dysfunction” AB 13,763 
S10 “cerebral blood flow” or “cerebral bloodflow” AB 33,465 
S11 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S9 OR S10 193,841 
S12 Elder* OR “older people” OR “older person” OR aged/ OR ageing 
OR aging OR senior OR geriatric AB 
2,361,227 
S13 S11 AND S12 36,198 
S14 "non-pharmacological treatment*" OR "nonpharmacological 
treatment*" OR "non pharmacological treatment*" AB 
4063 
S15 "non-pharmacological management" OR "nonpharmacological 
management" OR "non pharmacological management" AB 
2120 
S16 "non-pharmacological intervention*" OR "nonpharmacological 
intervention*" OR "non pharmacological intervention*" AB 
5964 
S17 14 OR 15 OR 16 4625 
S18 Physical AB 141,178 
S19 S13 AND S18 179 
S20 S11 AND S12 AND S17 44 
S21 S11 AND S17 169 
S22 compression ajd2 garment* AB 2493 
S23 compression adj2 stocking* AB 3196 
S24 compression adj2 bandag* AB 2009 
S25 compression adj2 wrap* AB 2695 
S26 stockings, compression/ AB 1615 
S27 abdominal binder AB 138 
S28 S22 OR S23 OR S24 OR S25 OR S26 OR S27 154,794 
S29 S13 AND S28 1408 
S30 S11 AND S28 5437 
S31 S13 AND S17 44 
S32 rehabilitation AB 45,333 
S33 S13 AND S32 108 
S34 S11 AND S32 10,191 
S35 exercise AB 93,653 
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S36 S35 AND S11 7912 
S37 S11 AND “physical maneuvers” or “physical man*” or “physical 
measures” AB 
103 
S38 diet AB and S11 65 
S39 fluid AND S11 936 
S40 water AND S11 140 
S41 meals AND S11 1206 
S42 food AND S11 1057 
S43 vasovagal AND management OR treatment AB  
S44 S11 AND “head up” OR “head-up” AB 1040 
S45 S11 and “electrical stimulation” AB 2167 
S47 Parkinson* OR Alzheimer* OR dementia OR “multiple sclerosis” 
OR “motor neuron*” OR stroke AB 
282,575 
S47 exp stroke/ MeSH AB 128,930 
S48 exp neurodegenerative disease*/ MeSH AB 14,461 
S49 exp dementia/ MeSH AB 82,503 
S50 exp multiple sclerosis/ MeSH AB 9104 
S51 exp cerebrovascular disorder/ MeSH AB 47,059 
S52 exp brain ischemia/ MeSH AB 8,9618 
S53 exp spinal cord injuries/ MeSH AB 46,684 
S54 exp brain injuries/ MeSH AB 105,520 
S55 craniocerebral trauma/ MeSH AB 11,371 
S56 exp central nervous system disease/ MeSH AB 19,412 
S57 exp brain damage, chronic/ MeSH AB 1562 
S58 Parkinson* adj2 disease AB 6701 
S59 S47 OR S48 OR S49 OR S50 OR S51 OR S52 OR S53 OR S54 
OR S55 OR S56 OR S57 OR S58 
705,295 
S60 S11 AND S59 27,078 
S61 S11 AND S17 AND S59 56 
S62 S11 AND intervention OR treatment 947 
S63 S11 AND “functional electrical stimulation” OR FES OR “electrical 
stimulation” OR “neuromuscular stimulation”  
9 
 1218 
AMED (EBSCO) 1219 
Search ID # Search formula Records retrieved 
S1 orthostatic adj2 hypotension AB 43 
S2 hypotension, orthostatic/ MeSH, AB 42 
S3 postural adj2 hypotension AB 12 
S4 orthostasis AB 6 
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S5 dizziness/ MeSH AB 275 
S6 “low blood pressure” AB 28 
S7 hypotension/ MeSH AB 177 
S8 vascular adj2 response AB 36 
S9 “autonomic dysfunction” AB 78 
S10 “cerebral blood flow” or “cerebral bloodflow” AB 98 
S11 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S9 OR S10 666 
S12 Elder* OR “older people” OR “older person” OR aged/ OR ageing 
OR aging OR senior OR geriatric AB 
15,557 
S13 S11 AND S12 91 
S14 "non-pharmacological treatment*" OR "nonpharmacological 
treatment*" OR "non pharmacological treatment*" AB 
73 
S15 "non-pharmacological management" OR "nonpharmacological 
management" OR "non pharmacological management" AB 
16 
S16 "non-pharmacological intervention*" OR "nonpharmacological 
intervention*" OR "non pharmacological intervention*" AB 
22 
S17 14 OR 15 OR 16 87 
S18 Physical AB 26,973 
S19 S13 AND S18 28 
S20 S11 AND S12 AND S17 0 
S21 S11 AND S17 0 
S22 compression ajd2 garment* AB 26 
S23 compression adj2 stocking* AB 21 
S24 compression adj2 bandag* AB 20 
S25 compression adj2 wrap* AB 3 
S26 stockings, compression/ AB 26 
S27 abdominal binder AB 6 
S28 S22 OR S23 OR S24 OR S25 OR S26 OR S27 76 
S29 S13 AND S28 0 
S30 S11 AND S28 0 
S31 S13 AND S17 0 
S32 rehabilitation AB 40,721 
S33 S13 AND S32 41 
S34 S11 AND S32 5 
S35 exercise AB 16,599 
S36 S35 AND S11 2 
S37 S11 AND “physical maneuvers” or “physical man*” or “physical 
measures” AB 
0 
S38 diet AB and S11 2 
S39 fluid AND S11 0 
S40 water AND S11 2 
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S41 meals AND S11 0 
S42 food AND S11 0 
S43 vasovagal AND management OR treatment AB 0 
S44 S11 AND “head up” OR “head-up” AB 0 
S45 S11 and “electrical stimulation” AB 5 
S47 Parkinson* OR Alzheimer* OR dementia OR “multiple sclerosis” 
OR “motor neuron*” OR stroke AB 
9734 
S47 exp stroke/ MeSH AB 5851 
S48 exp neurodegenerative disease*/ MeSH AB 156 
S49 exp dementia/ MeSH AB 1699 
S50 exp multiple sclerosis/ MeSH AB 1204 
S51 exp cerebrovascular disorder/ MeSH AB 109 
S52 exp brain ischemia/ MeSH AB 40 
S53 exp spinal cord injuries/ MeSH AB 3294 
S54 exp brain injuries/ MeSH AB 3074 
S55 craniocerebral trauma/ MeSH AB 2 
S56 exp central nervous system disease/ MeSH AB 69 
S57 exp brain damage, chronic/ MeSH AB 12 
S58 Parkinson* adj2 disease AB 27 
S59 S47 OR S48 OR S49 OR S50 OR S51 OR S52 OR S53 OR S54 
OR S55 OR S56 OR S57 OR S58 
15,637 
S60 S11 AND S59 163 
S61 S11 AND S17 AND S59 0 
S62 S11 AND intervention OR treatment 14 
S63 S11 AND “functional electrical stimulation” OR FES OR “electrical 
stimulation” OR “neuromuscular stimulation”  
0 
 1220 
PEDro (Physiotherapy Evidence Database) 1221 
Search ID # Search formula Records retrieved 
S1 orthostatic adj2 hypotension 19 
S2 hypotension, orthostatic 19 
S3 postural adj2 hypotension 6 
S4 orthostasis 2 
S5 dizziness 273 
S6 “low blood pressure” 413 
S7 hypotension 50 
S8 vascular adj2 response 53 
S9 “autonomic dysfunction” 36 
S10 “cerebral blood flow” or “cerebral bloodflow” 0 
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S11 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S9 OR S10 421 
S12 Elder* OR “older people” OR “older person” OR aged/ OR ageing 
OR aging OR senior OR geriatric 
 
S13 S11 AND S12  
S14 "non-pharmacological treatment*" OR "nonpharmacological 
treatment*" OR "non pharmacological treatment*" 
87 
S15 "non-pharmacological management" OR "nonpharmacological 
management" OR "non pharmacological management" 
73 
S16 "non-pharmacological intervention*" OR "nonpharmacological 
intervention*" OR "non pharmacological intervention*" 
94 
S17 S14 OR S15 OR S16 315 
S18 S11 AND S17 0 
S19 S11 AND compression 3 
S20 S11 AND electrical stimulation 4 
S21 stroke OR neurodegenerative disease* OR dementia OR multiple 
sclerosis OR neurological OR Parkinson* OR motor neuron* 
 
S22 S11 AND S21 2 
 1222 
Cochrane Central Register of Controlled Trials 1223 
Search ID # Search formula Records retrieved 
S1 orthostatic adj2 hypotension: TI, AB, KW 1287 
S2 "non-pharmacological" OR "nonpharmacological" OR "non 
pharmacological” OR treatment OR intervention OR 
management: TI, AB, KW 
1751 
S3 compression: TI, AB, KW 5616 
S4 S1 AND S2 22 
S5 S4 AND S3 20 
 1224 
Clinical Trials Register 1225 
 1226 
OpenGrey 1227 
Search formula Records retrieved 
abstract: (orthostatic hypotension OR postural hypotension OR low blood pressure 
OR cerebral blood flow) AND abstract: (nonpharmacological OR non-
pharmacological OR non pharmacological) AND abstract: (intervention OR treatment 
OR management) 
396 
TI: Title; AB: Abstract; KW: keyword 1228 
Search formula Records retrieved 
(orthostatic hypotension OR orthostatic; hypotension, neurogenic OR orthostatic; 
hypotension, dysautonomia) AND (treatment OR intervention OR management): TI, 
AB, KW 
134 
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Appendix II : Characteristics of included studies 
Eight non-pharmacological interventions for orthostatic hypotension were identified under two general categories: physical modalities (exercise, electrical 
stimulation, compression, compression and physical counter-maneuvers, physical counter-maneuvers, and sleeping with head up) and dietary measures 
(food and fluid intake). 
Physical modalities 
Exercise 










Description of main results 












N=9 unconscious within 
first three months of brain 
injury; (5 male) 
Mean age: 51 (± 20) years 
Tilt table with an integrated 
stepping device  
Intervention and control 
delivered in a random 
order on different days one 





of verticalization due 
to a syncope or 
presyncope 
symptoms such as 
tachypnea, 
tachycardia, pallor, 
or increase in 
sweating 
Secondary: state of 
consciousness 
according to Coma 
Recovery Scale-
Revised; influence of 
treatment on muscle 
tone using Modified 
Ashworth Scale 
There were significantly more 
incidences of presyncope on the 
conventional tilt table (P<0.05) at tilts 
of 50 or 70 degrees compared to the 
tilt table with integrated stepping. 
The binominal test as a cross-check 
showed significantly more treatment 
discontinuations on the conventional 
tilt table than on the tilt table with 






cardiogenic syncope with 
N=11 undertook aerobic 
physical training using 
N=10 undertook 
15 minutes of 
stretching and 
Resting and training 
HR, VO2 peak, VO2 
anaerobic threshold, 
The training group exhibited a 
tendency for higher peak HR, with 
VO2 peak and VO2 anaerobic 
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had positive head-up tilt 
test (3 male) 
Mean age: 32 (±10) years 
in intervention group; 26 
(±8) years in control group 
cycle ergometer for 12 
weeks 
Two supervised sessions 
plus two unsupervised 
sessions 
15 minutes of 
light walking for 
12 weeks  
2 supervised 
sessions 
sBP and dBP before 
and after 12-week 
training 
threshold than the control group. The 
training group exhibited a statistically 
significant difference (P<0.01) in 
syncope episodes between pre- and 
post-intervention.  
There was a significant difference 
(P<0.05) in the number of negative 
head-up tilt (72.7% in the training 










N=12 with vegetative state 
or minimally conscious 
state 3-18 months after 
acute acquired brain injury 
(8 male) 
Mean age: 65 (±8) years in 
intervention group; 63 
(±16) years in control 
group 
N=6 tilted to 65 degrees 
with a robotic tilt table 
system performing 18 
steps per minute of the 
lower limbs (hip and knee 
flexion) for 30 minutes 
three times a week for 24 
sessions 
N=6 tilted to 65 
degrees for 30 
minutes with no 
lower-limb 
movement 
HR and BP 
monitored at every 
tilt angle 
Coma recovery 
scale and level of 
consciousness scale 




n=4 withdrawn due to medical 
events. 
Intervention group showed a 
progressive reduction in OH during 
treatment; n=3 showed a complete 
absence of OH at the end of 
rehabilitation therapy.  
Control group showed more serious 
OH after 24 sessions of treatment. 
BP readings not reported, but the 
group tilted with robotic stepping 
experienced less OH during 
verticalization (48 and 4 seconds) 
compared to the control group (120 
and 187 seconds). 








N=30 (n=14 sub-arachnoid 
hemorrhage; n=4 severe 
brain trauma; n=4 intra-
parenchymal hemorrhage, 
n=2 ischemic stroke, n=3 
brain anoxia, n=3 other 
(17 male) 
Age range: 18-88 years 
Mean age: 54.2 years 
N=10 passive cycling in 
supine (protocol 2) 
N=10 passive stepping 





sBP and dBP, HR, 
respiratory rate, 
cerebral blood flow 
for participants with 
sub-arachnoid 
hemorrhage, venous 
blood, and blood 
plasma samples 
No significant absolute or relative 
difference in any of the BP 
components with passive cycling or 
passive stepping.  
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Groups Outcomes measured Main description of results 




USA, community N=24 elderly with OH (a 
subset of n=53 
participants from a larger 
study on a high-
resistance strength 
training in elderly people; 
all 24 showed orthostatic 
hypotension in the pre-
test) (7 male) 
Mean age: 71 (±5.8) 
years 
All participants underwent 8 
weeks heavy resistance, 
progressive strength training 
program, upper and lower 
limbs.  
Participants were 
discontinued from the study 
if more than two consecutive 
sessions were missed. 
i) Resting BP in supine, sitting, 
and standing positions 
ii) Resting HR in supine, sitting, 
and standing positions 
iii) Response to orthostatism in 
rising from supine after 10 
minutes and rising from a chair 
after five minutes 
Significant changes (P<0.05) in supine 
dBP (+3.2 mmHg), sitting systolic BP (-
3.9 mmHg), and standing HR (+4.9 
beats per minute). In response to 
orthostatic challenge, significant 
(P<0.05) improvements in sBP (+9.7 
mmHg), dBP (+4.7 mmHg) and HR 
(+3.2 beats per minute) for the rise 
from chair, and in dBP (+6.7 mmHg) 
rise from cot. Gains in strength were 
also noted. 




USA, community N=12 orthostatic 
hypotension. Only 8 
completed the protocol.  
N=8 (4 male) 
Age range: 63to 81 years 
N=8 completed an 8-week 
home-based resistance-
training program using 
elastic resistance bands. 10 
exercises (incorporating 
upper and lower limbs) were 
assigned and customized to 
each participant. 
Orthostatic testing: ECG and 
beat-to-beat BP continuously 
monitored and recorded. 
BP in supine, seated, standing 
one minute, standing two 
minutes, and during tilt table 
testing weeks 1 and 8 at rest, 
60-degree tilt, end tilt. 
Muscle strength testing 
(isometric and dynamic) 
Functional test of gait and 
mobility (Timed Up and Go 
Test) at baseline and 8 weeks 
At 8 weeks, significant increases 
occurred in dynamic strength in the 
chest press (P<0.017), quadriceps 
extension (P<0.017), and leg press 
(P<0.025); no significant differences 
occurred in isometric strength or in 
BPs. Functional mobility increased in 
seven out of eight participants.  
No falls during the investigation 
period. 
 










Brazil, community  N=30 Parkinson’s 
disease and n=16 healthy 
controls (33 male) 









Healthy controls  
sBP, HR, RR intervals 
(Valsalva maneuver and 
orthostatic stress), muscle 
strength using one repetition 
maximum. 
Compared with baseline, 
sBP fall was significantly 
reduced in the 
Parkinson’s disease 
training group (14 ± 11 
mmHg versus -6 ± 10 
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Age range: 63 (±8) 
(Parkinson’s Disease 
Control Group) 
Age range: 68 (±10) 
(healthy controls) 
mmHg; Parkinson’s 
disease control: -12 ± 10 
mmHg versus 11 ± 10 
mmHg; interaction 
P<0.05) 
In addition, after 12 
weeks, these parameters 
in the Parkinson’s 
disease training group 
achieved values similar to 
those in the health control 
group.) 
 




Group A description 
and sample 


















“active phase”) (4 
male) 
Mean age: 76.8 
(±7.9) years  
N=21 performed 10 full 
extensions of the ankle, 
knee, and hip joints of 
both limbs against a 
resistance band (6 kg 
load) held under their 
feet while supine in bed 
N=21 underwent 
testing, but did not 
perform any exercise 
prior to testing BP and 
HR 
 
sBP and dBP after 10 
minutes supine rest, 
immediately upon 
standing up, and after 
one, three and five 
minutes standing, HR, 
self-report orthostatic 
symptoms. Pre- and 
post-intervention.  
Medications taken at 
time of testing and 
intervention were 
recorded. 
The reduction of sBP was 
significantly smaller (P<0.01) at 
each time interval after standing 
up in the exercise group than in 
the control group (10 mmHg in 
the exercises group versus 27 
mmHg in the control group), but 
no difference observed in dBP or 
HR. Trend towards fewer OH 
symptoms in the exercise group 
compared to control during active 
testing (not significant). 
 




Groups Outcomes measured Main description of results 





N=12 spinal cord 
injury (12 male)  
N=6 experimental group 
performed upper limb 
exercises while undergoing 
BP and HR at 30 secs, 1.5, 2.5, three, 
four and five-minute intervals during tilt 
training. 
Pre-test termination angle score 
homogenous between experimental 
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mean time since 
injury 7.2 weeks 
Mean age: 40.3 
years 
Control group: n=6 
with quadriplegia; 
mean time since 
injury 8.2 weeks 
Mean age: 22.5 
years 
orthostatic training (tilted from 
0 to 70 degrees at 10-degree 
increments at five-minute 
intervals on a tilt table)  
N=6 control group underwent 
orthostatic training (tilted from 
0 to 70 degrees at 10 degree 
increments at five-minute 
intervals on a tilt table) 
Each participant received a score 1-10 
depending on step level at which they 
experienced OH (at which time the test 
was terminated). Credit was given for 
partial completion of time specified at 
each angle by awarding 0.2 of a score 
for each 30-second period completed. 
and control groups (P<0.1). Mean 
differences in the termination angle. 
Active, reciprocal, bilateral extremity 
exercise does not result in a 
significant change in tolerance of 
progressively higher vertical angles 
of tilt. The experimental group did not 
show increases in BP or demonstrate 
improved orthostatic tilt tolerance 
over the control group. Control group 
mean BP was 122/70 mmHg and 
experimental group was 117/76 
mmHg. 
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Electrical stimulation 
















complete) (11 male) 
n=15 healthy able-
bodied (gender not 
reported) 
Mean age at SCI: 
35 (±9.41) years 
Mean age able-
bodied: 29 (±6) 
years 
Fourteen SCI participants used a 
standing system: stationary 
standing for 30 minutes and 
dynamic standing using FES for 30 
minutes. Four electrodes, 
balanced symmetrical biphasic 
waveform with 35 Hz frequency, 
duty cycles of 11 seconds on, 60 
seconds off for channel 1 (tibialis 
anterior and gastrocnemius 
muscles) and 7 seconds on and 64 
seconds off for channel 2 
(quadriceps and hamstrings 
muscle groups). 
Fifteen able-bodied participants 
performed stationary standing for 
30 minutes and voluntary tiptoe 
contractions during 30 minutes of 
standing. 
 
Stroke volume, cardiac output, 
HR, sBP, dBP, TPR, MAP: 
measured in sitting, standing, 
after five minutes and 30 
minutes of standing in all 
participants for both static and 
dynamic standing. 
Significant reduction in sBP and dBP 
(P<0.05) and MAP during stationary 
standing in SCI subjects, while 
maintained in able-bodied. All BP values 
were maintained to pre-standing levels in 
SCI group during standing with FES. No 
changes in any variables for able-bodied 
participants.  
SCI participants demonstrated significant 
reductions (P<0.05) in all hemodynamic 
values for stationary standing at five and 
30 minutes (able bodied-reduction in SV 
and cardiac output at 30 minutes); 
compared to no change at five minutes 
when standing with FES, but at 30 
minutes standing with FES there was 
significant increase in hemodynamic 
values (HR and SV); able-bodied group 
maintained at five minutes, but at 30 
minutes dynamic standing cardiac output 
decreased and HR increased. 
 
 




Groups Outcomes measured Main description of results 











SCI participants used a 
standing system for stationary 
standing for 30 minutes and 
dynamic standing using FES for 
30 minutes (active standing 
Central hemodynamic 
responses of SV, cardiac 
output, HR, MAP, TPR, and 
rate pressure product during 
supine, sitting, and standing 
Overall, the tetraplegic group had a 
significantly lower sBP (P=0.013) and MAP 
(P=0.048) than the paraplegic group during 
passive standing. These differences were not 
detected during active standing. 
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bodied (gender not 
reported) 
Mean age SCI: 35 
(±9.41) years 
Mean age able-
bodied: 29 (±6) 
years 
group). Four electrodes, 
balanced symmetrical biphasic 
waveform with 35 Hz frequency, 
duty cycles of 11 seconds on, 
60 seconds off for channel 1 
(tibialis anterior and 
gastrocnemius muscles) and 7 
seconds on and 64 seconds off 
for channel 2 (quadriceps and 
hamstrings muscle groups). 
Able-bodied participants 
performed stationary standing 
for 30 minutes and voluntary 
tiptoe contractions during 30 
minutes of standing (passive 
standing group). 
With versus without order was 
counterbalanced. 
positions, and every five 
minutes during the 30 
minutes standing. 
Moving from sitting to standing sBP increased 
1.6% in the active standing group compared 
to a decrease in sBP of 8% in the passive 
standing group. When data were pooled from 
both groups and the overall groups response 
to active and passive standing were 
compared, the results showed that cardiac 
output, SV, and BP significantly decreased 
(P<0.05) during 30 minutes of passive 
standing, whereas TPR significantly 
increased (P<0.05). All hemodynamic 
variables were maintained during 30 minutes 
of active standing, and there were increases 
in rate pressure product and HR after 30 
minutes of active standing. 













Age range: 26-36 
years 
All participants underwent 
repeated measures: supine on 
tilt table with feet in contact with 
footboard. Six minutes rest at 0 
degrees for baseline 
measurements, followed by six 
4-minute stages for each tilt 
angle (0, 15, 30, 45, and 60 
degrees), followed by a four 
minute recovery. Repeated with 
and without electrical stim 
(biphasic waveform, 20 Hz 
frequency without any ramping, 
alternating 2 seconds on and 4 
seconds off periods of the 
quadriceps and ankle plantar 
flexors during the tilting 
procedure) 
Test terminated if sBP < 60 or 
dBP < 40 or severe orthostatic 
sBP, dBP, and HR taken at 
one-minute intervals during 
resting and tilting procedures 
(tilt angles: 0, 15, 30, 45, 
and  60 degrees).  
Subjective perception of 
orthostatic tolerance 
measured at one-minute 
intervals during tilting. 
sBP showed a progressive decrease with 
increasing tilt angle without the electrical 
stimulation. The electrical stimulation 
treatment appeared to attenuate the rate of 
sBP decrease. sBP at each degree of tilt with 
functional neuromuscular stimulation was 
higher. dBP was lower for all tilt angles 
without functional neuromuscular stimulation. 
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symptoms reported 
(fainting/headache). 






ward in medical 




N=2 sub-acute SCI 
(C7), 2 weeks 
since injury (both 
male) 
Age: 62 and 65 
years 
Both participants underwent 
four weeks of ES therapy, four 
times per week for one hour per 
day. ES was applied on the 
rectus abdominis, quadriceps, 
hamstrings, and gastrocnemius 
with 35 Hz frequency, pulse 
width 250 µs. The current 
amplitude was increased 
incrementally from 0 mA to the 
maximum tolerated by patients, 
which was 130 mA. 
sBP and dBP pre- and post-
testing, every minute 0 to 65 
degrees on tilt table, MAP 
and HR were obtained 
during pre-test and post-
tests with and without ES-
evoked muscle contractions. 
Symptom Scale 
Questionnaire for Orthostatic 
Intolerance was conducted 
during all tests to measure 
their OH symptoms. 
Subject A improved his orthostatic symptoms, 
but did not recover from clinically defined OH 
based on the 20-minute duration requirement. 
With concurrent ES therapy, 60 degrees 
head-up tilt BP was 89/62 mmHg compared 
with baseline BP of 115/71 mmHg. Subject B 
fully recovered from OH demonstrated by BP 
of 105/71 mmHg during the 60-degrees head-
up tilt compared with baseline BP of 124/77 
mmHg. Both patients demonstrated longer 
tolerance time during head-up tilt with 
concomitant ES (subject A: pre-test = four 
minutes, post-test without ES = six minutes, 
post-test with ES = 12 minutes; subject B: 
pre-test = four minutes, post-test without ES = 









N=128 mild or 
moderate stroke 
4.6 ± 1.2 days 
post-stroke (56 
male) 
Mean age: 58.3 
(±1.2) years 
 
N=38 were treated with ROBO-
FES (robotic tilt table and 
functional electrical stimulation) 
for 30 days. A six channel 
stimulator was used and 
electrodes placed over biceps 
femoris, quadriceps femoris and 
gastrocnemius of either leg. 
Stimulation was synchronized 
with robotic leg movements 
varying between 5 and 100 mA. 
N=35 were treated with ROBO 
(robotic tilt table only)  
N=31 were the control group  
N=24 dropped out 
British Medical Research 
Council Strength Scale, sBP 
and dBP, SV, cerebral blood 
flow using transcranial 
Doppler ultrasonography, 
Barthel Index for activities of 
daily living, pulsatility index, 
resistance index. 
All measures taken at 
baseline and post-
intervention 
None of the participants in the ROBO or 
ROBO-FES groups had OH or orthostatic 
reactions when put into a vertical position, but 
52% of the control participants showed OH.  
Did not state whether participants were doing 
any standing/vertical activities in the usual 
therapy as part of their rehabilitation. 








N=10 SCI; n=4 
cervical, n=6 
thoracic ; 1-29 
N=10 underwent the same 
testing and acted as their own 
control. Tilted head-up to 70 
degrees from supine; four 10-
Participant report of any 
symptoms of orthostatic 
hypotension, such as 
headache, dizziness, and 
sBP decreased significantly during head-up 
tilt and increased significantly during dynamic 
FES, especially toward the end. dBP 
increased significantly during passive 
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years since injury 
(6 male) 
Age range: 27-59 
years  
minute conditions involved, with 
a 10-minute rest between each 
condition: 1) passive head-up tilt 
with no intervention, 2) passive 
stepping using a motorized 
stepper (described in 
intervention section) 3) isometric 
FES of leg muscles (described 
in intervention section), and 4) 
dynamic FES of leg muscles 
combined with passive stepping 
(described in intervention 
section).  
FES was applied to four muscle 
groups: tibialis anterior, 
hamstring, quadriceps femoris 
and triceps surae of both legs. 
Stimulation was bipolar and 
biphasic, with a maximum pulse 
width of 300 µs and stimulation 
frequency of 40 Hz. 
light-headedness. Inferior 
vena cava imaging in the 
transverse plane. 
Electromyography signals of 
the leg muscles were 
recorded only during passive 
stepping because cyclic 
passive movements of the 
legs can induce rhythmical 
electromyography activities. 
Beat-to-beat BP recorded 
non-invasively every minute 
for 10 minutes during each 
of the testing conditions. 
stepping and dynamic FES. Mean BP 
increased significantly only during dynamic 
FES. Statistical significance data for individual 
conditions not provided. However, results of a 
three-way ANOVA demonstrate that sBP, 
mean BP, and HR all increased significantly 
(P=0.004, P=0.006 and P=0.026) during FES. 
Passive stepping significantly increased sBP, 
dBP, and mean BP (P=0.009, P=0.182, 
P=0.0102). 
The effects of FES on SV and mean BP were 
greater than those of passive stepping. When 
combined, FES and passive stepping did not 
interfere with each other, but did not 
synergistically increase SV or mean BP. 
Thus, the present study suggests that FES 
delivered to lower limbs can be used in 
individuals with SCI to help them withstand 
orthostatic stress.  






N=5 SCI; n=4 
cervical, n=1 
thoracic), 3 years 
post-injury, (3 
male), all with OH 
Age range: 23-32 
years 
All participants underwent the 
same testing, attending two 
testing sessions separated by at 
least one day. 
Once OH occurred, 
transcutaneous stimulation was 
applied to the skin between 
thoracic 7-8 spinous processes. 
The stimulation was delivered at 
30Hz as monophasic, 1-ms 
pulses, to provide afferent input 
to the region of the spinal cord 
where sympathetic 
preganglionic neuron cell bodies 
are located. The current was 
increased from 10 mA until BP 
normalized, up to a maximum 
Following 10 minutes of rest 
in supine, the test began 
with 15 minutes of supine 
measurements, after which 
participants were passively 
moved to the sit-up position 
and supported while sBP, 
dBP, and HR 
measurements were 
recorded for an additional 
15 minutes. 
Participants ranked their 
symptoms of nausea/ 
dizziness one to 10 (10 
being most severe) each 
minute of the test 
During the orthostatic challenge, all 
individuals experienced hypotension 
characterized by a 37 ± 4 mm Hg decrease in 
sBP, a 52 ± 10% reduction in cardiac 
contractility, and a 23 ± 6% reduction in 
cerebral blood flow (all P<0.05), along with 
severe self-reported symptoms. Electrical 
stimulation completely normalized BP, 
cardiac contractility, cerebral blood flow, and 
abrogated all symptoms. Non-invasive 
transcutaneous electrical spinal cord 
stimulation may be a viable therapy for 
restoring autonomic cardiovascular control 
after SCI. 
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70 mA, and maintained for at 
least one minute. 
Electromyography of the lower-
limb skeletal muscles was 
recorded to confirm skeletal 
muscle contractions were not 
occurring and therefore the 
pressor responses were not 
attributed to the skeletal muscle 




























N=21 elderly persons 
with symptomatic 
progressive OH (9 
male) 
Mean age: 70 (± 11) 
years 
All 21 underwent same 
testing conditions. 
Elastic compression 
bandage applied over 
the legs (40-60 mmHg 
at the ankles and 30-40 
mmHg at the hips) for 
10 minutes, then an 
abdominal bandage 
was added for a further 
10 minutes (20-30 
mmHg). 
The modified Italian tilt 
protocol was used, 
consisting of 60 
degrees passive tilting 
for 20 minutes followed 
by 0.4 mg 
nitroglycerine challenge 
for a further 20 minutes 
During active sham 
treatment, the same 
elastic bandages were 
applied (5 mmHg 
overall). 
 SSS-OI (baseline and one-
month post-treatment with 
elastic leg compression 
stockings.  
sBP and HR: supine and 60 
degrees, pre- and post-leg 
bandage phase, end of leg 
plus abdomen phase 
 
In the intervention group, 90% of 
all participants remained 
asymptomatic versus 53% in the 
control group (P<0.02). During 
the month before evaluation, the 
mean SSS-OI score was 35.2 (± 
12.1) with dizziness, weakness 
and palpitations accounting for 
64% of the total score. The SSS-
OI score decreased to 22.5 
(±11.3) after one month of 
therapy (P<0.01). In the control 
group, sBP decreased from 125 
(±18) mmHg immediately after 
tilting to 112 (±25) mmHg after 10 
minutes of sham leg bandaged 
and to 106 (± 25) mmHg after 20 
minutes despite the addition of 
sham abdominal bandage. In 
comparison, active therapy group 
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when the passive 
phase failed to induce 
syncope. 
Participants were 
trained and wore 
compression stockings 
(40-60 mHg at ankles 
and 30-40 mmHg at 
hips) for one month 
after testing. 
BP was 129 (±19) mmHg, 127 
±17 mmHg (P<0.003vs control), 













stroke (duration < 4 
weeks post-stroke) 
with OH (18 male) 
Mean age: 59.77 
(±17.03) years in 
intervention group and 




binder 40 mmHg 
pressure and 
pneumatic calf 
compression 30 mmHg 
pressure 
N=13 received elastic 
compression 
bandaging from the 
metatarsal head to the 
popliteal fossa in a 
single layer spiral 
manner with overlap 
Number of days taken to 
attain orthostatic stability 
modified Rankin scale to 
measure independence of 
specific tasks. 
Hemodynamic responses, 
measuring sBP and dBP, 
and HR parameters at 0, 30, 
45, and 60 degrees tilt. 
The percentage of participants <4 
weeks post-stroke wearing 
pneumatic abdominal binder and 
pneumatic calf compression 
achieving orthostatic stability was 
significant on the third (50%; 
P<0.019) and sixth day (100%; 
P<0.007). 
No significant difference in the 
modified Rankin scale scores 
between groups. 







N=15 with Parkinson’s 
disease and 
orthostatic 
hypotension; (8 male) 
Age range: 66-75 
years 
After 3 days of testing, 
all participants received 
an elastic abdominal 
binder (20 ± 2 mm Hg 
pressure). Binder worn 
for two hours and then 
assessed (pre- and 
post). After a one-day 
interval abdominal 
binder (20 ± 2 mmHg) 




testing, wore an 
abdominal binder (20 
±2 mm Hg pressure) or 
placebo binder (3 ±2 
mm Hg pressure 
applied on the 
abdominal wall) for two 
hours, re-tested on the 
tilt table and 
subsequently removed 
the binder. After one-
day washout, the tests 
were repeated to 
ensure all participants 
Primary: mean BP changes 
at 3, 5, and 10 minutes in 
supine, 60 degrees 





Symptom Assessment and 
Orthostatic Hypotension 
Daily Activity Scale scores 
after 4-week open-label 
period. 
Compared to the placebo binder, 
the abdominal binder was 
associated with an increase of 
the third minute tilt mean BP by 
10 ± 10.2 mmHg; +3.5, +14.5 
(P<0.006).  
During the open-label phase, 12 
patients wore the abdominal 
binder an average of 5.6 ± 0.6 
days/week, 50% to 75% of 
daytime. At 4-week follow-up, the 
Orthostatic Hypotension 
Questionnaire score decreased 
by -2.2 points (P<0.003), the 
Orthostatic Hypotension 
Symptom Assessment (OHSA) 
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had been tested in 
both abdominal and 
placebo binder. 
Participants then wore 
an abdominal binder 
(20 ± 2 mmHg 
pressure applied on 
the abdominal wall) 
every day during the 
daytime for four weeks 
sub score by -1.7 points (P< 
0.003) and the Orthostatic 
Hypotension Daily Activity Scale 
by -3.9 (P< 0.007). No side 










N=14, SCI T5 or 
above  
Age range: 18-73 
years 
Abdominal binder fitted 
to provided firm support 
around the abdomen 
from the anterior 
superior iliac crest to 
the costal margin of the 
rib cage (no mmHg 
pressure provided). 
Participants wore the 
abdominal binder daily 
for the duration of the 
trial (6 months) 
N=3 participants 
ceased wearing the 
binder daily. No data 
provided on daily 
wearing time. 
Participants acted as 
their own controls and 
underwent testing in 
both conditions 
MAP 
Respiratory measures (peak 
expiratory flow, forced 
expiratory flow, forced vital 
capacity)  
Voice measures 
Measured at three time 
points: six weeks, three and 
six months, in supine and 
sitting in own wheelchair. 
There was no statistically 
significant improvement in MAP, 
maximal expiratory pressure or 
sound pressure level. 
Overall, an abdominal binder 
resulted in a statistically 
significant improvement in forced 
vital capacity (P<0.005), forced 
expiratory volume in one second 
(P<0.05), peak expiratory flow 
(P<0.02), maximal inspiratory 
pressure (P<0.01), and maximum 
sustained vowel time (P<0.01).  






N=61 admitted with 
acute medical 
conditions requiring 







underwent testing with 
or without compression 
bandages applied to 
both legs from ankle to 
thigh before moving 
from supine to seating. 
Extensible bandages 
were used obtain a 
uniform pressure of 
 BP, ECG tracing, HR, O2 
saturation, dizziness, and 
palpitations were recorded 
prior to seating and during 
one, three, and five minutes 
in sitting. 
Prevalence of postural 
hypotension was identical in the 
unbandaged versus bandaged 
state (55.7%). However, 
dizziness, palpitations, 
accelerated HR, and decreased 
O2 saturation over five minutes 
were more prevalent in the 
unbandaged versus bandaged 
state (P<0.01, P<0.001, P<0.05, 
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infectious diseases; 
other n=5) (41 male) 
Mean age: 77.8 (±9.7) 
years 
about 30 mmHg. The 
bandages were 
stretched along both 
legs so that the 
designed rectangles 
were transformed into 
squares. 
P<0.001, respectively). In the 
unbandaged state, presence 
versus absence of OH was 
associated with significantly 
greater incidence of palpitations, 
tachycardia and decline of O2 
saturation over time (P< 0.04, 
P<0.03, P<0.03, respectively). 
 




Groups Outcomes measured Main description of results 
















Mean age: 75.1 (± 
8.3) years  
 
Compression extensible 
bandages were applied along 
both legs from the ankle to the 
thigh before seating. The 
bandages were stretched so that 
the designed rectangles were 
transformed into squares to 
obtain a uniform pressure (40 
mm Hg at the ankle). All 
participants underwent the same 
testing: two sessions. Day 1 
bandages but without 
compression. Day 2 compression 
bandages of approximately 40 
mmHg pressure. Participants 
assisted from supine to sitting, 
not standing 
BP, HR, O2 saturation, and 
the occurrence of dizziness 
or palpitations were 
recorded prior to, and during 
one, three, and five minutes 
in sitting. 
Compression bandages prevented postural 
hypotension in 21 of 49 patients and 
decreased the degree of postural BP fall 
(P<0.001). sBP and dBP were higher in the 
bandaged group following one minute of 
sitting (sBP: 146.6 ± 31.1 mmHg bandaged 
versus 141 ± 28.1 mmHg unbandaged; 
P=0.055; dBP: 72 ± 13.9 mmHg bandaged 
versus 68.7 ± 16.9 mmHg unbandaged; 
P=0.05) and following five minutes of sitting 
(sBP: 147 ± 28.6 mmHg bandaged versus 
141 ± 27.1; P=0.03;  dBP: 72.4±14.6 
bandaged versus 67.9 ± 17.4 mmHg 
unbandaged; P=0.01). 






N=73 bedridden for 
≥8 hours with 




Before moving from supine into 
sitting, compression extensible 
bandages were stretched along 
both legs from the ankle to the 
end of the thigh, so that the 
designed rectangles became 
transformed into squares, to 
sBP and dBP, heart rhythm 
with ECG, self-report 
symptoms of OH in supine 
and at one, three and five 
minutes of sitting. 
Compared with the non-bandaged state, OH 
was registered in only 53.4% of bandaged 
participants (P<0.001). Moreover, the 
appearance of OH symptoms decreased to 
34.2% (P<0.001).  
On the second day (bandaged), supine dBP 
values were higher in the persisting 82.1 ± 
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Mean age: 75.2 
(±9.0) years 
obtain a uniform pressure of 
about 30-40 mmHg at the ankle. 
All participants underwent same 
testing: day 1 no compression, 
day 2 compression. 
18 mmHg versus non-persisting OH group 
73.6 ± 14 mmHg (P<0.027). In the bandaged 
state, OH symptoms were significantly 
reduced in the non-persisting OH group 
35.3% (P<0.003).  
In participants with persistent OH, sBP was 
significantly increased wearing bandages 
(147.0 ± 28 mmHg) versus unbandaged 
(136.2 ± 26.5 mmHg) (P<0.004). 







N=10 elderly with 
OH (6 male) 
Age range: 62-89 
years (mean 77.2 
years) 
All participants underwent same 
testing: supine rest then 
positioned into standing 90 
degrees upright with tilt table for 
3 minutes, then positioned into 
supine. Elastic compression 
hosiery (tights) fitted to bilateral 
lower limbs. 
sBP and dBP, HR in supine; 
one, two and three minutes 
in supine and 90 degrees tilt. 
Authors refer to the fact that 
"orthostatic dizziness was 
abolished in seven out of 10 
participants” but do not 
report how this was 
measured. 
Short-term efficacy with compression hosiery 
in elderly people with symptomatic OH and a 
history of falls. (Not reported if OH was 
reason for falling or other factors.) 





USA, clinic N=14 confirmed 
diagnosis of OH 
(n=3 multiple system 
atrophy; n=9 PAF; 
n=2 diabetic 
autonomic 
neuropathy) (5 male) 
Age range: 31-78 
years 
All participants underwent testing 
from supine to 80 degrees head-
up tilt ± compression (40 mmHg) 
to calves/thighs/abdomen and all 
compartments combined to 
evaluate the impact compression 
of different body parts on 
orthostatic BP and tolerance. 
Visual analogue scale 
(numerical) rating change in 
symptoms and duration of 
stand with compression 
garments; sBP and dBP in 
supine and 80 degrees 
verticalization, HR, end 
diastolic volume index, 
cardiac output index, and 
peripheral resistance index. 
Visual analogue scale of 
severity of symptoms after 
each session. 
Head-up tilt with compression resulted in 
significant improvement (P<0.001) of sBP 
115.9 ± 7.4 mmHg compared to 89.6 ± 7.0 
mmHg without compression. Maximum 
improvement was with all combinations of 
compression. Abdominal compression alone 
was the only single compartment to 
significantly reduce OH (P<0.01). 
Participants reported that a combination of all 
compartments was most efficacious in 
reducing symptoms. 







N=12 healthy elderly 
people and younger 
adults 
N=6 elderly people 
(6 male) 
All 12 participants stood up 
rapidly (<5 seconds) and 
remained free standing for three 
minutes, then returned to supine 
for six minutes and repeated the 
supine-to-stand protocol. 
Esophageal temperature, 
skin temperature, blood flow 
velocity, arterial BP (beat-to-
beat changes in BP), cardiac 
output from HR and SV, 
TPR in supine and standing. 
All participants completed the normothermic 
and passive heat conditions of both control 
and compression leggings. No difference in 
supine or initial seconds in standing in either 
groups. In minute 6 of standing, those 
wearing compression leggings in the 
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Mean age: 70 (±4) 
years 
 
N=6 younger adults 
(6 male) 
Mean age: 29 (±4) 
years 
 
Standing was terminated and 
participants positioned supine 
with legs elevated if presyncope 
symptoms presented. This was 
completed at normal body 
temperature and repeated at 
elevated body temperature (0.5 
degrees Celsius). In the elevated 
temperature trials participants 
wore long-sleeved and legged, 
two-pieced, tube-lined perfusion 
suit. Passive heating was 
achieved by circulating warm 
water through the suit and 
wrapping participants in reflective 
foil blanket with periodic warm 
water circulation to maintain the 
elevated temperature. 
normothermia increased TPR in older 
participants but dropped in younger 
participants. In contrast, standing and 
heated, wearing compression leggings 











N=9 SCI (n=4 
above T6, n=5 
below T6), at least 
two years post 
injury (9 male) 
Age range: 25-54 
years 
All participants performed two 
maximal wheelchair exercise 
tests using a wheelchair 
ergometer (increasing Watts 
every 2 minutes) without and 
with garment compression 
stockings (21 mmHg (ankle) to 
15 mmHg (calf).  
The progressive wheelchair test 
started with a 30-minute rest 
period using the wheelchair 
ergometer to stabilize various 
cardiorespiratory variables. This 
was followed by a six-minute 
warm up at a constant speed 
with no load. The load was then 
increased by 10W increments 
for low-level paraplegics and 5W 
for high-level paraplegics, every 
VO2/VCO2 measurement 
during test, sBP, dBP, 
finger arterial pressure, SV, 
Q, TPR, HR variability, 
wavelet high and low and 
very low frequency power.  
All tested pre- and post-
exercise sitting in 
wheelchair, without 
garment compression 




No differences in VO2, W max, HR, or BP 
with or without GCS. Significantly higher 
(P<0.05) low-frequency wavelet and lower 
high-frequency wavelet (high-frequency 
wavelet is a parasympathetic marker) with 
garment compression stockings 3 to 8 
minutes post exercise. Decrease in mean 
relative risk with garment compression 
stockings immediately after exercise. 
Norepinephrine at rest was significantly 
higher (P<0.05) with garment compression 
stockings. Epinephrine and norepinephrine 
both increased with exercise with and 
without garment compression stockings. 
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Age: 61 years 
Tilt-table testing from supine 0 to 
45 degrees and 60 degrees and 
back to supine without, and then 
with inflatable external leg 
compression to bilateral lower 
limbs (calf and thigh). 
sBP and dBP in 0, 45, and 
60 degrees tilt, SV index, 
HR, perfusion index, 
peripheral perfusion tissue 
oxygenation. 
With the application of 15 mmHg pressure 
during 45 and 60 degrees head up, SV 
index and HR were maintained, and no 
presyncope symptoms occurred.  
With the external leg compression 
constantly inflated with a pressure of 15 
mmHg, the participant could remain in the 
upright position and could be mobilized 
during physiotherapy wearing inflatable 
external leg compression.  
External leg compression succeeded in 
improving presyncope symptoms and 
preventing OH for several hours. 
 
Physical counter-maneuvers 




Groups Outcomes measured Main description of results 











PAF, n=1 Hodgkin's 
disease, n=1 
medulla oblongata 
bleed, n=1 multiple 
sympathectomies); 
n=6 healthy controls 
(11 male) 
Age range: 20-65 
years 
Intervention group: leg muscle 
pumping (tiptoeing) or tensing 
(leg crossing) for one minute, 
started after 2 minutes of active 
standing. Maneuvers were 
performed in a random order, 
each for one minute, with one 
minute of quiet standing in 
between. 
 
Control group: active standing  
sBP and dBP, HR, SV, 
cardiac output, peripheral 
resistance assessed before 
standing (10 seconds) and 
after one minute of tiptoe, 
quiet standing and leg 
crossing assessed over 10 
seconds at first and after 
one and two minutes in 
standing. 
Mean BP, sBP, and dBP significantly 
decreased in patient group (P<0.01) 
following one minute of standing; systemic 
vascular resistance did not change from 
supine; rise in HR seen mainly in patients 
due to non-PAF patients. 
Tiptoeing did not result in a clear distinction 
between initial and sustained effects 
between PAF and non-PAF patients. 
Leg-crossing induced an initial increase in 
BP, SV, and cardiac output both in normal 
participants and patients with PAF and non-
PAF. There was a small increase in MAP of 
only 13 mmHg in the patient group, but the 
two minutes until volitional 
exhaustion, or the subjects were 
unable to maintain the required 
speed. 
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authors suggested that this increase is of a 
similar magnitude to the changes seen in 
pharmacological interventions such as 








N=9 with neurogenic 




atrophy) (4 male) 
Mean age: 53 (± 18) 
years 
N=9 underwent four training 
sessions in the laboratory, then 
performed the physical counter-




contraction, leg crossing, knee 
flexion, toe raise, neck flexion, 
abdominal contraction, thigh 
contraction. 
Session 1: all physical counter-
maneuvers performed in random 
order. Sessions 2 and 3 three: 
biofeedback training on three 
maneuvers selected by the 
participant that provided the best 
symptomatic relief to optimize 
performance. Session 4: 
practicing maneuvers without 
feedback. 
Global Symptomatic 
Improvement Score: judging 
the effectiveness of physical 
counter-maneuvers; 
improvement in orthostatic 
BP and continued 
improvement with follow-up 
telephone survey. BP 
measured at baseline, 
before and after each 
counter-maneuver. 
Global Symptomatic Improvement Score: 
The findings support the hypothesis that 
physical counter-maneuvers can significantly 
increase BP. Squatting produced the most 
dramatic change in arterial pressure (40.6 
±23.2 mmHg) (P<0.0004). Continued 
improvement: Standing time improved by 
8.33 ± 5.8 mmHg minutes. Participants 
reported continued counter-maneuver 
performance of 3.83 ± 3 .1 mmHg 
maneuvers per day. Biofeedback training: 
statistically significant improvement seen 
with genuflection-contraction (P<0.002), leg 
crossing (P<0.016), and thigh contraction 
(P<0.007) after three or four 45-minute 
sessions. 
van Lieshout 








OH (4 male); age 
range 18-65 years 
N=6 healthy controls 
(gender not 
reported); age 
range: 28-34 years 
All participants performed 
exercises in fixed order: stand up, 
cross legs, squat. Stand for 10 
minutes maximum or until 
symptoms occur. Then cross legs 
for 30 seconds, then resume 
standing. Squat when "BP 
became low again" (BP cut off 
not described). 
sBP and dBP measured in 
all three positions. 
Standing without any physical maneuvers, 
five out of seven participants reported 
orthostatic dizziness within 10 minutes (four 
unable to remain standing). After leg-
crossing, all participants could stand for 10 
minutes or more with a difference of 14 
mmHg (SD ± 6) in mean BP. A larger 
increase in sBP was observed with squatting 
with a difference of 44 mmHg (SD ± 18). 




N=8 OH (n=5 
autonomic failure, 
Each participant sat on seats of 
varying heights (48 cm, 38 cm, 20 
sBP and dBP, HR, cardiac 
output, SV, and TPR. 
BP was higher in sitting than standing. Due 
to increase in SV and cardiac output. Lower 
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Age range: 35-70 
years 
cm) and performed different 
maneuvers such as squatting, 
crossing legs, and standing in a 
crossed-leg position. 
All measures taken: 
Standing: with and without 
contraction of crossed legs 
Sitting: with and without leg-
crossing sat on Derby chair, 
Fishing chair, and footstool 
Squatting 
chairs associated with high increment in BP. 
Crossing legs on the Derby chair produced 
greater increment in sBP and dBP (P<0.01; 
mean change 16 mmHg and 9 mmHg no leg 
crossing and 49 mmHg and 25 mmHg with 
leg crossing). Standing crossing legs 
increased sBP and dBP significantly 
(P<0.01; 14 mmHg and 7 mmHg standing 
and no leg crossing versus 29 mmHg and 15 
mmHg crossing legs in standing) and in 
seven out of eight of the participants, 
produced a higher increase than sitting on 
the Derby chair. Sitting on a fishing chair 
was perceived as most comfortable. Derby 
chair was deemed unstable/did not relieve 
symptoms/small seat. Low stool was hard to 
stand up from; uncomfortable or experienced 
dizziness on standing. 










Mean age: 26.4 
(±12.4) years 
Physical counter-maneuvers: 
bending forward, squatting, leg 
crossing, and abdominal 
compression using an inflatable 
belt. Counter-maneuvers were 
initiated after standing up, when 
sBP had fallen by 40 mmHg or 
dBP had fallen by 30mmHg, or 
presyncope had occurred. 
HR, sBP, and dBP, mean 
BP, cardiac output, TPR, 
and calf volume 
 
Mean BP increased significantly (P<0.005) 
during bending forward 20.0 mmHg, 
squatting (P<0.002) 50.8 mmHg and 
abdominal compression 5.8 mmHg (P<0.04) 
but not during leg-crossing. Squatting and 
abdominal compression also induced a 
significant increase in cardiac output during 
squatting (P<0.02) 18.1 mmHg and during 
abdominal compression 7.6 mmHg 
(P<0.014).  
 
Physical counter-maneuvers and compression 




Groups Outcomes measured Main description of results 






All participants performed 
Protocol 1: evaluated in a 40 to 
sBP and dBP in supine, 40 
degrees head-up-tilt, 15 
Protocol 1 (n=7) head-up tilt from supine. 
Compression resulted in an increase in BP 
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PAF, n=7 multiple 










Age range: 35-79 
years 
60 degree head-up tilt position, 
the effect of abdominal 
compression on caval vein and 
femoral diameter, arterial BP, and 
hemodynamics wearing an anti-
gravity suit.  
Protocol 2: anti-gravity suit 
standing, then standing and legs 
crossed with 20 mmHg 
abdominal compression, 40 
mmHg abdominal compression 
All participants performed 
protocol 3: investigated the ability 
to maintain standing BP by an 
elastic binder (9 or 12 inch), 
compression 15-20 mmHg 
seconds preceding 
compression, first 15 
seconds of 40 mmHg lower 
abdominal compression, last 
15 seconds of 40 mmHg 
compression, and 5 seconds 
after compression and in 
standing with graded 
pressure 20/40 mmHg ± leg 
crossing. HR, cardiac output, 
TPR, and changes in the 
inferior caval and femoral 
vein diameter. 
with increase in SV and cardiac output and 
no change in peripheral resistance diameter 
of veins, decreases caval vein but femoral 
vein increases.  
Protocol 2 (n=12) binding and 
countermeasures increased BP, but there 
was no significant difference between 
conditions.  
Protocol 3 n=9 significant increase in BP 
(P<0.05; 11 mmHg sBP and 6 mmHg dBP) 
and increase SV (13% P<0.05) and cardiac 
output (12% P<0.05) and reduction in 
peripheral resistance (-7% P<0.05) 
Elastic abdominal compression increased 
standing BP with 15/6 mmHg (range -3/3 to 
36/14, P<0.05). 
 











USA, laboratory N=13 with neurogenic 
orthostatic 
hypotension, (n=5 
PAF; n=4 multiple 
system atrophy; n=2 
Parkinson’s disease; 
n=1 post-radiation 
baroreflex failure; n=1 
autoimmune 
autonomic 
neuropathy. (7 male) 
Age range: 62-79 
years 
Participants were 
ambulatory and able 








from supine to standing 
without abdominal 
compression; moving 
from supine to standing 
with either a 
conventional or 
adjustable abdominal 




All participants moved 
from supine to 
standing without 
abdominal 
compression, then with 
either a conventional 
or adjustable 








were asked to stand up 
and adjust the 
Primary: Continuous sBP, 
dBP, and HR in supine, and 
standing 
Secondary: Orthostatic 
Symptom Scale (visual 
analogue scale); Symptom 
Change Scale (visual 
analogue scale) 
Standing without abdominal 
compression resulted in a large 
orthostatic fall (change in sBP, 
−57 mmHg) and severe 
orthostatic intolerance 
(Orthostatic Symptom Scale, 5 
points).  
Compared with no abdominal 
binding, 10 mmHg of abdominal 
compression while supine prior to 
rising was effective in attenuating 
OH with both the conventional 
(change in sBP, −50 mmHg; 
interquartile range, −33 to −70 
mmHg; P=<0.03) and pull string 
(change in sBP, −46 mmHg; 
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developing pre-
syncope. 
standing; and while still 
erect, subsequent 
reduction of 
compression to a level 
the subject believed to 
be tolerable for a 
prolonged period. 
compression to a 
maximal tolerable 
level, and then 
subsequently reduce 
the compression to a 
level the subject 
believed to be tolerable 
for a prolonged period. 
It was unclear if this 
was immediate or 
within a specific time of 
standing. 
interquartile range, −34 to −75 
mmHg; P<0.01) binders. 
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Sleeping with head up 




Groups Outcomes measured Main description of results 







were tested on an 
outpatient basis, 





OH (3 male) 
Age range: 23-65 
years  
 
Each patient received a diet 
containing 150-200 mmol sodium 
and a minimal water intake of 
2000 mL per day. This three-
week study was divided into one-
week phases. To assess 
changes during the steady state 
alone, the first three days of each 
week were excluded from the 
analysis; values were presented 
as the average for the last four 
days of each period. 
Interventions were delivered in 
one-week blocks. In the first 
week (control), they did not have 
medication (apart from two 
bedridden patients because of 
severe OH who had 0.1 mg 
fludrocortisone) or head tilt. In the 
second week, all patients started 
to sleep in the 12 degrees head-
up tilt position. During the third 
week treatment involved a 
combination of sleeping in the 
head-up tilt position and 
fludrocortisone administered at 
2200 hours. 
Orthostatic tolerance as 
measured by Orthostatic 
Disability Score; maximum 
standing time, terminated 
either at the onset of severe 
orthostatic dizziness or after 
a maximum period of 10-
minute standing; sBP, dBP, 
and mean BP) for control; 
head-up tilt; head-up tilt and 
fludrocortisone, and follow-
up; fluid balance (changes in 
total body water content 
assessed by measuring 
changes in body weight).  
Follow-up at 14 months.  
Combined treatment reduced orthostatic 
dizziness in all patients (P < 0.001), and 
increased the maximal standing period to at 
least 10 minutes. 
Head-up tilt alone (n=4) reduced the BP 
decrease after 1 minute of standing from -
64/-42/-25 ± 27/21/17 mmHg to -53/-37/-23 ± 
31/24/20 mmHg (P<0.01 for sBP). The 
addition of fludrocortisone to head-up tilt 
(head-up tilt/fludrocortisone) (n=5) further 
reduced the BP decrease after one minute of 
standing from -63/-40/-24 ± 20/12/11 mmHg 
to -21/-19/-8 ± 12/10/5 (P<0.05 for sBP, 
mean and dBP). BP at maximal standing 
time increased during combined treatment 
58/47/42 ± 9/8/7 mmHg initially to 95/69/57 ± 
27/22/20 mmHg (P<0.05 for sBP and mean 
BP), and remained unchanged during the 14-
month (range 8-70 month) follow-up period. 






N=100 with OH 
Mean age: 76 years 
Intervention group n=66, control 
group n=34 
Intervention group had the head 
of their bed elevated six inches 
with blocks for six weeks. 
Hemodynamic variables: 
sBP, dBP (24-hour 
ambulatory blood pressure), 
MAP, HR, cardiac output, 
SV, TPR. Plus weight, 
frequency of dizziness, 24-
Sleeping with head up six inches for six 
weeks was tolerated by participants and both 
groups reported overall improvement and 
had fewer episodes of dizziness per week 
before versus after (P=0.0039). Participants 
sleeping with head up were more likely to 
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hour urinary sodium and 
volume, and presence of 
ankle edema. 
have leg edema. Compliance to the 
treatment was 77%. 
However, there were no significant 
differences between the two groups in 
hemodynamic variables. Changes in sBP 
between pre and post were: -1.45 mmHg 
supine and 1.98 mmHg standing; dBP 2.42 
mmHg supine and 2.61 mmHg standing, 
MAP 0.94 mmHg sitting and 2.07 mmHg 
standing. 
Study concluded that sleeping head up six 
inches for six weeks is not recommended as 
an outpatient treatment for OH in elderly 
people. 
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Dietary measures 
Food intake 




Groups Outcomes measured Main description of results 










OH) (5 male)  
Mean age: 81.6 







Mean age: 85.3 
(± 5.23) years 
 
Testing over two consecutive 
days. Day 1: BP monitoring 
every 30 minutes in supine 
between 0800 and 1800 hours. 
Supine sBP readings were used 
before the start of lunch and 60 
minutes after a normal 2500 kj 
lunch to measure the 
postprandial sBP change 
Day 2: participants received 
their usual breakfast and 
pursued their usual activities in 
the ward (newspaper reading or 
rest). Participants with 
Parkinson’s disease received 
their usual physio mid-morning 
and afternoon, orthostatic BP in 
active standing and head-up 
tilting tests performed after a 
normal 2500 kj lunch (lunch 
eaten in sitting). All participants 
underwent orthostatic tests: 
active standing and head-up 
tilting tests, performed 60 and 
40 minutes before the start of 
lunch. 
sBP, HR in supine, active standing 
and head-up tilt testing both pre- 
and post-prandial. dBP was 
recorded but not presented in the 
literature. Day 1 BP testing in 
supine, day 2 testing in sitting. 
Participants with Parkinson’s disease had a 
significant (P<0.01) postprandial sBP drop 
from 154.3 ± 26.2 to 127.7 ± 18.1 mmHg in 
supine position compared to healthy 
controls; in participants with Parkinson’s 
disease, the drop was moderately correlated 
to orthostatic sBP responses and 
significantly correlated to the pre-prandial 
supine baseline systolic BP. There was a 
greater fall of sBP with passive than with 
active standing with both groups, which was 
greater in the PD group. No difference in 








young adults (16 
male) 
All participants underwent the 
same testing: three recumbent 
BPs measured two minutes 
apart after five minutes supine 
sBP and dBP, HR Supine BP: elderly had higher sBP and dBP. 
HR was higher in both groups after meals. 
Standing sBP and dBP was similar between 
groups. The younger group had higher HR 
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78 years  
rest. The subject stood up and 
BP was measured one minute 
later. Protocol was performed 
beginning at 2:30 p.m. on 
admission and 1:00 p.m. the 
following day at discharge. 
Readings included first thing in 
the morning 7:00 am, before 
and after meals, mid-morning, 
mid-afternoon, mid evening and 
bedtime (10:30 p.m.). Postural 
BP protocol was performed 45 
minutes after the beginning of 
each meal. 
with standing. Elderly people showed drop 
pre- to post-meal BP (not seen in young). 
HR was higher post-meal in both groups. 














severe OH (n=3 











All participants underwent same 
conditions: first day 3 meals, 
versus second day (at least one 
day apart) 6 meals. Total calorie 
intake was the same. 
BP monitoring and self-initiated 
readings after five minutes of lying, 
sitting, or standing. With only three 
meals, participants have extra set of 
positional recordings (six in total 
same as a six-meal day). 
Participants kept a symptom diary. 
Regardless of meal the size, drop in BP with 
positional change was similar but three 
meals showed a significantly lower BP in all 
positions than six meals (131 mmHg after 
large meals and 151 mmHg after small 
meals P<0.005).  
Between meals, a larger drop in BP was 
seen with three meals (sBP: 88 mmHg 
versus 104 mmHg, P<0.002; dBP: 48 mmHg 
versus 63 mmHg, P<0.0001). Fewer OH 
symptoms were experienced with six meals. 
 
Fluid intake 
Fluid intake and exercise 




Groups Outcomes measured Main description of results 
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OH, all able to 
walk (3 male) 
Mean age: 63.9 
(±6.1) years 
All participants underwent same 
testing: supine 10 minutes rest, 
standing 10 minutes, rest in 
supine, exercises in supine 
(pedal ergometer), rest in 
supine, standing five minutes. 
Identical protocol followed on 
two separate occasions: one of 
which participants drank 480 
mL distilled water at room 
temperature within five minutes 
after first stand. Participants 
were randomly assigned to start 
with the protocol without water 
(n=3) and with water (n=5) with 
on average 10.8 days between 
the two assessments. 
Participants were asked to drink 
the water within five minutes. 
sBP and dBP in supine one (rest), 
standing one (five minutes standing), 
supine two (rest), cycling (exercise), 
supine three (rest), stand two. 
HR, subjective perception of 
hypotension related symptoms. 
All participants had severe OH pre-exercise 
with prompt recovery of BP in supine. Five 
minutes after drinking water, there was a 
significant (P<0.05) rise in BP in supine 
position. With exercise there was a clear fall 
in BP (sBP: 42.1 ± 24.4 mmHg and dBP: 
25.9 ± 10.0 mmHg) with a modest risk in HR; 
this occurred even after water ingestion. sBP 
remained low after exercise but was 
significantly higher (P<0.05) after water 
intake two and five minutes of standing (74.5 
± 32.9 mmHg) and 74.3 ± 28.4 mmHg 
without water versus 103.5 ± 34.4 mmHg 
89.0 ± 16.7 mmHg with water), resulting in 























Mean age: 36 (± 
4) years 
Participants drank 120 mL, 240 
mL, and 480 mL of tap water at 
room temperature (20 degrees 
Celsius) in less than five 
minutes on separate days.  
All participants underwent 
Protocol 1: drinking 480 mL of 
tap water at room temperature 
(20 degrees C) in less than 5 
minutes.  
All participants underwent 
Protocol 2: consumption of 
standardized high carbohydrate 
breakfast. 
Blood pressure (supine, seated, 
upright); HR  
Protocol 1: seated, BP, and HR 
measured every five minutes for 30 
minutes, standing, returned to 
seated for a further 35 minutes with 
BP and HR taken every five minutes, 
standing BP determined. 
Protocol 2: seated for 30 minutes 
and BP and HR taken every five 
minutes, participants ate a meal, 
then BP and HR taken every five 
minutes for 90 minutes while seated. 
Repeated twice (once with water 
before the meal, one meal only). 
Before water drinking, seated BP was 117 ± 
23/67 ± 10 mmHg, which fell to 83 ± 20/53 ± 
11 mmHg after one minute of standing. 
Thirty-five minutes after drinking 480 mL of 
water at room temperature in less than five 
minutes, seated BP increased to 150 ± 25/78 
±13 mmHg and after standing for one minute 
BP was 114 ± 30/66 ± 18 mmHg. 
Pre-meal BP 138 ± 41/77 ± 17 mmHg. Within 
20 minutes after starting to eat, BP 
decreased, reaching a nadir of 43 ± 36/20 ± 
13 mmHg below baseline after 90 minutes. 
Drinking 480 mL of water in less than five 
minutes prior to a test meal, BP increased 
with a peak that was 36 ± 23/9 ± 10 mmHg 
above baseline after 20 minutes (P<0.001 
ANOVA compared to meal with no water). 
Drinking water attenuated orthostatic 
tachycardia in patients with idiopathic 
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Valsalva maneuver, hyperventilation, 
cold pressor, hand grip. 
orthostatic intolerance (123 ± 23 beats per 
minute at baseline to 108 ± 21 beats per 
minute after water drinking.) 
(Inconsistencies in reported number of 




















Mean age: 62 
(±9.5) years 
 
(n=7 PAF) (3 
male) 
Mean age: 59 
(±10) years 
All 14 participants underwent 
the same testing: standing BP 
and HR were measured before 
and 15 and 35 minutes 
following ingestion of 480 mL 
distilled water within five 
minutes. Patients remained 
seated for 15 minutes after 
water ingestion, with beat to 
beat cardiovascular indices 
measured with the Portapres 2 
device with subsequent 
Modelflow analysis. 
sBP and dBP before, and 15 and 35 
minutes after ingestion of 480 mL 
distilled water. 
Calculation of cardiac output, TPR, 
and SV using Modelflow analysis. 
Standing prior to water ingestion caused a 
significant fall in sBP in all patients (110.6 ± 
25.1 mmHg seated and 79.5 ±21.5 mmHg 
standing; P<0.01). After water ingestion, 
standing sBP was significantly higher 
(P<0.001) at 15 minutes (101.0 ± 23.3 
mmHg) and 35 minutes (99.6 ± 24.0 mmHg), 
with an improvement in orthostatic 
symptoms. 
The time to first significant rise in seated BP 
occurred at five minutes post-water ingestion 
in PAF and at 13 minutes in multiple system 
atrophy. These increases were accompanied 
by increases in total minutes post peripheral 
resistance, reaching significance by five 
minutes in PAF and 13 minutes in multiple 
system atrophy. There were no significant 
changes in cardiac output, SV, or ejection 
fraction. 
BP: blood pressure; dBP: diastolic blood pressure; ECG: electrocardiogram; FES: functional electrical stimulation; HR: heart rate; O2: oxygen; OH: orthostatic 
hypotension; PAF; pure autonomic failure; RR: intervals between successive heartbeats; sBP: systolic blood pressure; SCI: spinal cord injury; SSS-OI: 
Specific Symptom Scale Questionnaire for Orthostatic Intolerance; SV: stroke volume; TPR: total peripheral resistance; VCO2: maximum rate of expired 
carbon dioxide; VO2: maximum rate of oxygen consumption
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Table 1: Critical appraisal results of eligible randomized controlled trials 
Citation Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 
Fanciulli et 
al67 
U N Y U N N Y Y U Y Y Y Y 
Faghri & 
Yount71 
N N N N N N Y N Y Y Y Y N 
Figueroa et 
al72 
U U Y N N U Y Y N Y Y Y Y 
Fan et al55 U U Y N U U Y N Y Y Y Y N 
Kanegusuku87 Y Y Y N N N Y Y Y Y Y Y Y 
Gorelik et al81 U U Y N N U Y Y U Y Y Y Y 
Luther et al65 Y N Y N N N Y N Y Y Y Y Y 
Phillips et al84 Y Y U Y Y Y Y Y Y Y Y Y Y 
Podoleanu et 
al63 
Y Y Y Y N N Y Y Y Y Y Y Y 
Rocca et al69 Y Y N N N U Y Y Y Y Y Y Y 
Takahagi et 
al86 
U U Y N U U Y Y Y Y Y Y Y 
Taveggia et 
al64 
Y N Y N N N Y Y Y Y Y Y Y 
Vijayakumar 
et al88 
U Y Y U U U Y U U Y U Y Y 
Total % 46.15 38.46 76.92 15.38 7.69 7.69 100.0 69.23 69.23 100.0 92.3 100.0 84.61 
              
Y = Yes, N = No, U = Unclear; JBI critical appraisal checklist for randomized controlled trials: Q1 = Was true randomization 
used for assignment of participants to treatment groups?; Q2 = Was allocation to treatment groups concealed?; Q3 = Were 
treatment groups similar at baseline?; Q4 = Were participants blind to treatment assignment?; Q5 = Were those delivering 
treatment blind to treatment assignment?; Q6 = Were outcome assessors blind to treatment assignment?; Q7 = Were treatment 
groups treated identically other than the intervention of interest?; Q8 =  Was follow-up complete, and if not, were strategies to 
address incomplete follow-up utilized?; Q9 = Were participants analyzed in the groups to which they were randomized?; Q10 = 
Were outcomes measured in the same way for treatment groups?; Q11 = Were outcomes measured in a reliable way?; Q12 = 
Was appropriate statistical analysis used?; Q13 = Was the trial design appropriate, and any deviations from the standard RCT 
design (individual randomization, parallel groups) accounted for in the conduct and analysis of the trial? 
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Table 2 presents the results of the critical appraisal for eligible quasi-experimental studies. Cause and 
effect was clear in all but one study. In five studies, Q2 and Q3 were not applicable because there 
were no comparisons made. There was no control group in nine of the 28 studies. Q7 was deemed 
not applicable to one study because no comparisons were made. 
Table 2: Critical appraisal results of eligible quasi-experimental studies 
Citation Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 
Bouvette et 
al73 
N N N N Y Y U U Y 
Brilla et al74 Y N/A N/A N Y Y Y Y Y 
Denq et al75 Y Y Y Y Y Y Y Y Y 
Elokda et al76 Y Y Y Y Y N Y Y Y 
Faghri & 
Yount77 
Y Y Y Y Y N Y Y Y 
Gorelik et al82 Y U U Y Y Y Y Y Y 
Gorelik et al83 Y Y Y Y Y Y Y Y Y 
Hamzaid et 
al89 
Y N/A N/A N Y Y Y Y Y 
Henry et al51 Y N/A N/A N N U Y Y U 
Humm et al52 Y Y Y Y Y Y Y Y Y 
Kuznetsov et 
al90 
Y Y Y Y Y Y Y Y Y 
Loew et al70 Y Y Y Y Y Y Y Y Y 
Lopes P et 
al78 
Y Y U Y Y Y Y Y Y 
Lucas RAI et 
al91 
Y Y Y Y Y Y Y Y Y 
Mader SL.79 Y Y Y Y Y Y Y Y Y 
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Y Y Y Y Y Y Y Y Y 
Rimaud, D. et 
al68 
Y Y Y Y Y Y Y Y Y 
Shannon JR, 
et al66 
Y Y Y N Y Y Y Y Y 
Smit AAJ56 Y Y Y N Y N/A Y Y Y 
Smit AA57 Y Y Y Y Y Y Y Y Y 
Ten Harkel et 
al59 
Y Y Y Y Y Y Y N Y 
Ten Harkel et 
al58 
Y Y U N Y Y Y Y Y 
Tutaj et al93 Y N/A N/A N N Y Y Y Y 
van Lieshout 
et al60 
Y Y N Y Y Y Y U Y 
Wadsworth et 
al92 
Y Y Y Y Y Y Y Y Y 
Yoshida et 
al85 
Y Y Y Y Y Y Y Y Y 
Young & 
Mathias54 
Y Y Y Y Y Y Y Y Y 
Zion et al80 Y N/A N/A N Y Y N/A Y Y 
% 94.12 79.41 64.71 61.76 94.12 79.41 94.12 88.24 97.10 
Y = Yes, N = No, U = Unclear, N/A – not applicable; JBI critical appraisal checklist for quasi-experimental studies; Q1 = Is it 
clear in the study what is the 'cause' and what is the 'effect' (i.e., there is no confusion about which variable comes first)?; Q2 = 
Were the participants included in any comparisons similar?; Q3 = Were the participants included in any comparisons receiving 
similar treatment/care, other than the exposure or intervention of interest?; Q4 = Was there a control group?; Q5 = Were there 
multiple measurements of the outcome both pre and post the intervention/exposure?; Q6 = Was follow up complete and if not, 
were differences between groups in terms of their follow up adequately described and analyzed?; Q7 = Were the outcomes of 
participants included in any comparisons measured in the same way?; Q8 = Were outcomes measured in a reliable way?; Q9 = 
Was appropriate statistical analysis used? 
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Table 3 presents the critical appraisal results for the eligible case report study. The intervention was 
not clearly described but all other aspects of methodological quality were reported. 
Table 3: Critical appraisal results of eligible case report  
Citation Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 
Helmi61 Y Y Y Y N Y Y Y 
% 100.0 33.33 100.0 66.66 66.66 100.0 66.66 100.0 
Y = Yes, N = No, U = Unclear; JBI critical appraisal checklist for case report studies; Q1 = Were patient's demographic 
characteristics clearly described?; Q2 =  Was the patient's history clearly described and presented as a timeline?’ Q3 = Was 
the current clinical condition of the patient on presentation clearly described?; Q4 = Were diagnostic tests or assessment 
methods and the results clearly described?; Q5 = Was the intervention(s) or treatment procedure(s) clearly described?; Q6 = 
Was the post-intervention clinical condition clearly described?; Q7 = Were adverse events (harms) or unanticipated events 
identified and described?; Q8 = Does the case report provide takeaway lessons? 
Confounding factors were not identified and not strategy to deal with confounding factors in the case 
control study. All other aspects of methodological quality were met as presented in Table 4. 
Table 4: Critical appraisal results of eligible case control study 
Study Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 
Galizia et al62 Y Y Y Y Y N N Y Y Y 
Total % 100.0 100.0 100.0 100.0 100.0 0.0 0.0 100.0 100.0 100.0 
Y = Yes, N = No, U = Unclear; JBI critical appraisal checklist for case control study; Q1 = Were the groups comparable other 
than the presence of disease in cases or the absence of disease in controls?; Q2 =Were cases and controls matched 
appropriately?; Q3 =  Were the same criteria used for identification of cases and controls?; Q4 = Was exposure measured in a 
standard, valid and reliable way?; Q5 = Was exposure measured in the same way for cases and controls?; Q6 = Were 
confounding factors identified?; Q7 = Were strategies to deal with confounding factors stated?; Q8 = Were outcomes assessed 
in a standard, valid and reliable way for cases and controls?; Q9 = Was the exposure period of interest long enough to be 
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